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Poor stability in the harsh environment and enzymatic degradation in gastrointestinal (GI)
tract are major challenges for applications of natural biopolymer-based nanoparticles as oral
delivery vehicles. In this project, chitosan was firstly modified by grafting stearic acid on its
backbone via an eco-friendly redox reaction to improve its amphiphilicity. The polymeric
nanoparticles were prepared using stearic acid-conjugated chitosan and sodium caseinate via
gentle stirring and mild heating. Oxidized dextran was used as a cross-linker to strengthen the
integrity of nanoparticles in simulated GI fluids. Two biopolymer-based nanoparticle delivery
systems were prepared via different crosslinking methods. Both curcumin and astaxanthin
(ASTX) were applied to determine their encapsulate capacity for lipophilic bioactive
compounds. The major objectives of this dissertation, which is divided into four studies, are to
1) prepare chitosan derivative with strong amphiphilicity suitable for interaction with lipophilic
compounds; 2) fabricate and characterize two types of biopolymer-based nanoparticles; 3)
systematically evaluate the effect of crosslinkers on the stability of nanoparticles in simulated
GI fluids; 4) determine the encapsulation capacity and oral delivery potential of nanoparticles
using curcumin and ASTX. The results suggested that the biopolymer-based nanoparticles
prepared in the present study hold promising features to be oral delivery vehicles to carry
lipophilic bioactives for future applications in food and pharmaceutical industries.
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Chapter 1
Introduction

1

The field of food nanotechnology has experienced tremendous growth over the last
decade, and significant efforts have been focused in the area of development of delivery
systems for food bioactive compounds and nutrients. It has been well believed that
nanotechnology has the great potential to revolutionize agriculture and food systems [1, 2].
Encapsulation of nutrients into nano-scale delivery systems provides many novel applications
to address unmet challenges, including protection of labile and sensitive nutrients against
degradation in harsh environment, dispersing water insoluble compounds into aqueous phase,
modification of sensory attributes, improvement of bioavailability of poorly absorbed bioactives,
as well as targeting delivery to the specific site to maximize their health benefits, and many
other applications. The nano-scale delivery systems encompass many sub-categories, such
as polymeric and lipid nanoparticles, nanoemulsions, liposomes, nanofibers, etc. The
fabrication approaches of such delivery systems generally include two basic principles, i.e.
“top-down” (physical or mechanical processes) and “bottom-up” (chemical processes)
methods, which have been compressively reviewed by Acosta [3]. These methods have also
been given special focus in the development of nano-scale materials for applications in food
industry in the last decade [4]. Nevertheless, no matter which method is adopted to fabricate
nano-scale vehicles for nutrient delivery, the most important decision is to properly select foodcompatible biomaterials. In the fields of biomedicine and pharmaceutics, any biomaterials,
either natural or synthetic, may be used as long as they are biocompatible and biodegradable.
However, unlike drug delivery systems, this decision is much harder to be made in food
industry. One must be very cautious in selecting the appropriate biomaterials for future food
2

applications. Foods have a very complex matrix, compared to drugs which can be considered
as simple as a single pill or tablet or injection. Any delivery systems for nutrients will be
eventually incorporated into certain food matrix, which may have specific microenvironment
depending upon the food products, such as pH, solubility, and dispersibility Meanwhile, such
delivery systems must be intact under food processing conditions including homogenization,
thermal and high-pressure treatment, as well as pasteurization. Importantly, they should
neither alter the sensory of attributes nor affect the appearance of final food products.
Therefore, the selection of biomaterials to fabricate nutrient delivery systems in food industry
is actually more rigorous than pharmaceutical industry. The ideal fabrication materials for
nutrient delivery systems are the biomaterials having food origins as they are originally part of
the food products and can easily fulfill above-mentioned requirements. These biomaterials are
primarily food polysaccharides and proteins. By carefully modulating their physicochemical
properties, different designs of nano-scale delivery systems can be developed and tailored for
various applications in functional food [5].

In the last decade, chitosan (CS) has attracted great attention due to its excellent
physicochemical properties, such as biocompatibility, biodegradability, non-toxicity, abundant
renewable sources, and low cost [6]. Studies have demonstrated that CS is a promising
candidate material to prepare nanoparticles for oral delivery [7, 8]. In addition, various
modifications in CS have been performed to improve its functionalities, such as aqueous
solubility and resistance to enzymatic degradation [9]. Recently, complexation between CS

3

derivatives and other biopolymers has drawn increasing attention to formulating nanoparticles
as delivery vehicles for bioactives [10].

Proteins are a class of large biomolecules that consist of one or more long chains of amino
acid residues. In recent years, numerous food proteins have been applied for developing
Generally recognized as safe (GRAS) delivery vehicles due to their unique properties, such
as emulsification, foaming, gelation, and water binding capacity [11]. Animal proteins are
usually hydrophilic, or amphiphilic which can be considered as block copolymer with both
hydrophobic and hydrophilic amino acid residues. Some proteins are well-characterized for
their gelation properties which are recently being utilized to develop nanoscale gel structures
for nutrient delivery purpose, while others may form self-assembly structures when dispersed
in a specific aqueous phase. In this study, sodium caseinate (NaCas) was applied for
developing nanoparticles via electrostatic interaction with CS derivative coating.

To further strengthen the association between different biopolymers, solidify the
nanoparticles’ structure, and improve the stability in GI tract, synthetic cross-linkers (i.e.
glutaraldehyde (GLA)) were commonly adopted in nanoparticles fabrication process. The
formation of covalent bonds between cross-linkers and biopolymers is able to protect the
nanoparticles from dissociation caused by reduced protonation and enzymatic degradation.
Nevertheless, the toxicity problems still remain. Therefore, there is an urgent need to develop
a naturally derived and GI-stable biopolymer-based oral delivery vehicle without potential toxic
corss-linkers to carry lipophilic bioactives for future applications in food and pharmaceutical
industries.
4

The main objective of this project is to prepare an oral delivery system for lipophilic
bioactives using CS derivatives and other biopolymers. The CS derivative which is suitable for
lipophilic bioactives was modified using an eco-friendly free radical induced grafting method.
The preparation method of nanoparticles was optimized and model lipophilic bioactives were
used to investigate the loading capacity and controlled release of the as-prepared
nanoparticles. Our central hypothesis is that the GI stability of natural biopolymer-based
nanoparticles will be enhanced using non-toxic cross-linker and the encapsulation of lipophilic
bioactive compounds will be achieved.

5

Chapter 2
Literature review

Part of this chapter, including tables and figures, has been published in Carbohydrate
Polymers, 2016, 151, 624-639, International Journal of Biological Macromolecules, 2018,
120, 775-782, and Nutrient Delivery, 251-291, and reprinted with permission from Elsevier
6

2.1. Protein-based nano-scale delivery systems for nutrients

Food proteins, which have been widely used in preparation of nanoparticle delivery
systems, can be classified into two groups: plant proteins like zein, gliadin, soy protein, lectin,
etc; and animal proteins, such as whey protein, casein, collagen, gelatin and silk protein.
Animal proteins have attracted tremendous attentions due to their excellent amphiphilicity and
high affinity to lipophilic nutrients/drugs. For instance, milk proteins, such as caseins, have
been reported to self-assemble or co-assemble into stable spherical micellar structures that
allow encapsulation and delivery of a variety of small molecules, including both nutrients and
drugs [12]. On the other hand, compared to animal proteins, many plant proteins are more
hydrophobic in nature and easier to self-assemble to stable structures without involving harsh
processing condition, such as thermal treatment and/or the toxic cross-linkers [13].

2.1.1 Casein based protein-based nanoparticles for nutrient delivery

Caseins are amphiphilic proteins which have high level of hydrophobic and hydrophilic
amino acid residues. Hence, caseins naturally occurred in self-assembled spherical micelles
with an average diameter of 150 nm [14]. Sodium caseinate, a water-soluble form of casein
obtained by precipitation of casein micelles at its isoelectric point, has many nutritional values
with desired physicochemical properties and it is recently proven to be an excellent nanoscale
carrier for nutrients [15].

Some bioactive lipids, such as ω-3 fatty acids and β-carotene have been encapsulated to
investigate the casein-based nanoscale delivery system. Being the major representative of ω7

3 fatty acids, docosahexaenoic acid (DHA) has many health benefits. Nevertheless, DHA is
highly prone to oxidation due to its polyunsaturated structure, resulting in undesirable offflavors and odors. In order to prevent its beneficial properties, DHA has been encapsulated
into the casein-based nanoparticles [16]. Zimet et al. prepared two types of DHA loaded casein
nanoparticles: the first one was formed with adding calcium and phosphate, and the particle
size was in a range of 50-60 nm [17]. The second one (without calcium and phosphate) had
an average diameter of 288.9 nm. Both of them showed significantly water-solubility and
excellent protective effect against oxidation. As a consequence, it might enable the enrichment
of foods and beverages, such as ice cream, milk and yogurts by incorporating this delivery
system to promote health of wide populations. Another bioactive lipid that has been studied is
β-carotene. β-carotene is widely applied in the food industry as the main dietary source of provitamin A, but it is very sensitive to heat, light and oxygen. Sáiz-Abajo and coworkers
synthesized β-carotene encapsulated casein micelles using self-assembly method [18]. In
order to evaluate the protective effect, stability of micelles during the most common industry
treatments was measured, including pasteurization, sterilization, high hydrostatic pressure
and baking. The results showed that lower degradation of β-carotene was observed under all
thermal process, which indicated that the casein micelles are able to provide remarkable
thermal protective effect to heat sensitive compounds.

Besides, some essential oils and fat-soluble vitamins have also been encapsulated into
casein-based nanoparticles [19-24]. Vitamin D2 plays an important role in calcium metabolism.
To protect this sensitive hydrophobic nutraceutical, re-assembled casein micelles were
8

produced [22]. According to the encapsulation efficiency results, 5.5 times more vitamin D2
concentrated in micelles than that in serum. The author also demonstrated that the casein
micelles can protect vitamin D2 from degradation induced by UV-light. In another study, a
vitamin D3 loaded casein micelles with a diameter of 91 nm has shown the significantly
protective effect against heat- and storage-induced degradation [19]. All of these enhanced
functionalities of nutrients using casein-based nanoparticles represent future applications in
the functional foods and pharmaceutical products.

2.1.2 Whey protein-based nanoparticles for nutrient delivery

Whey protein is one of the most commonly applied animal proteins in the field of food and
pharmaceutical science. It is a mixture of globular proteins isolated from byproduct of cheese
processing. Similar to soy protein, whey protein comes in four high protein products, including
concentrate (WPC), isolate (WPI), hydrolysate (WPH) and native whey, varying in the purity
of protein content. There are two major components in whey protein, i.e. α-lactoglobulin and
β-lactoglobulin. The α-lactoglobulin, accounting for 25% of whey protein, is a globular
metalloprotein that contains four disulfide bridges [13]. While the β-lactoglobulin accounts for
65% protein in whey protein. It is a small globular protein (18.3 kDa), containing two disulfide
bridges and a free thiol group which structure can be well maintained at low pH. As a result,
β-lactoglobulin exhibits a highly resistant to enzymatic degradation in the stomach and the
potential to be a candidate for nutrient delivery system [25, 26].

9

The primary application of the development of whey protein-based nanoparticles is to
protect and transport nutraceutical bioactives for oral administration. Many nutrients have
been encapsulated in whey protein-based nanoparticles. It has been reported that a chitosanWPI based delivery matrix was prepared to encapsulate catechin [27], a water-soluble
polyphenol from green tea with low bioavailability. The catechin encapsulated nanoparticles
had remarkable stability under gastrointestinal tract, evidenced by positive charge below pH
7.2. Furthermore, 56.5% of released catechin was observed in simulated GI conditions at the
end of 24 h. The results showed that the carrier exhibited a satisfactory controlled release
behavior and the bioavailability of catechin was greatly improved. Besides polyphenols, fatty
acid has also been chosen as a model nutrient to develop suitable delivery system. Numerous
studies have indicated that ω-3 poly-unsaturated fatty acids (ω-3 PUFA) have many beneficial
effects on human health, such as prevention of cognitive disorder, development of the brain
and nervous system, as well as the regulation of blood pressure, immune and inflammatory
response [28-30]. Nevertheless, the benefits were restricted due to its poor water-solubility
and high sensitivity to oxidative degradation. Zimet and coworkers synthesized βlactoglobulin-pectin based nanoparticles as a vehicle to entrap ω-3 PUFA molecules [17]. The
nanoparticles provided a sustained protection for hydrophobic nutraceuticals evidenced by
encapsulation efficiency and stability analysis. However, the in vivo studies are significantly
lacking to confirm the biological efficacy of whey protein-based nanoscale delivery systems.
Furthermore, the allergenicity of β-lactoglobulin (the major whey protein in bovine milk without
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any counterpart in human’s milk) is another concern that may limit its applications in food
industry [26].

2.1.3 Zein-based nanoparticles for nutrient delivery

Zein is the major storage protein from corn and accounts for 35-60% of total protein in
corn. Zein has a unique amino acids profile consisting three quarters of hydrophobic and one
quarter of hydrophilic amino acid residues, which defines zein as a prolamine by its solubility
that it is only soluble in 50-95% alcohol. Zein has three major fractions α-, β-, and γ-zein and
a minor fraction δ-zein, with α-zein being the main type zein commercially available in the
market [31]. Although zein is directly derived from food, it is deficient in essential amino acids
(tryptophan and lysine) and thus has a negative dietary nitrogen balance. Thus, zein has not
been used in food products for human consumption. Nevertheless, its unique physicochemical
properties have made zein an extremely popular food biopolymer in the development of
nanoscale delivery systems for nutrients.

Since 1990s, zein microspheres and nanoparticles received extensive research interest in
the field of biomedicine and drug delivery, due to its GRAS regulatory status and easy
preparation procedures. However, the attention of zein nanoparticles for nutrient delivery in
food science has not been well received until last decade. Essential oils are the first bioactive
food compounds that have been studied for encapsulation in zein nanoparticles in 2005 [32],
and since then zein nanoparticles have been studied for many other lipophilic bioactive
compounds, including, essential oil [33], fish oil [34], vitamins [35, 36], polyphenols [37], etc.
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The compounds to be encapsulated are usually dissolved in ethanol and mixed with zein in
aqueous ethanol solution, prior to pouring into aqueous phase to induce the liquid-liquid
dispersion. The encapsulation efficiency can be easily measured by determining the
compound concentration in the supernatant after centrifuging down zein nanoparticles. Zein
nanoparticles are capable to trap the lipophilic bioactive compounds in the core during phase
separation process by strong hydrophobic interactions and thus providing excellent controlled
release rate. However, when tested in simulated gastrointestinal fluids with digestive enzymes,
zein failed to protect the bioactive compounds from burst release, which was primarily due to
the susceptibility of zein molecules to proteinases. To solve this problem, biopolymer coatings,
including chitosan and carboxymethyl chitosan are needed to prevent zein from fast hydrolysis
by enzymes [35, 36, 38]. The coated zein nanoparticles exhibited improved encapsulation
efficiency and slower release rate in the simulated gastrointestinal conditions. In addition to
the in vitro studies, a recent in vivo study demonstrated that zein nanoparticles were able to
significantly improve the bioavailability of daidzin when orally administered into mice. The
pharmacokinetic profile of daidzin, including the maximum plasma concentration and area
under the curve, was enhanced 2.4 folds compared with that of daidzin solution control. Both
the in vitro and in vivo study provide solid scientific evidence that zein-based delivery system
is an effective strategy to improve the bioavailability of poorly absorbed nutrients.

2.1.4 Soy protein-based nanoparticles for nutrient delivery

Soybean, one of the most widely cultivated plants in the world, is a good source of protein.
Some traditional foods made of soybean are quite popular in human’s diet, like soy milk, soy
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sauce, tofu and tofu skin, etc. Basically, three types of high protein products can be processed
from dehulled and defatted soybeans, named soy flour, concentrates, and isolates, depending
on the protein concentrations. Among them, isolates, also known as soy protein isolate (SPI),
has attracted great attentions in recent years. SPI consists of two major components: glycinin
with a molecular weight of 340-375 kDa and β-conglycinin with a molecular weight of 140-170
kDa [39]. These components exist as sphere molecules containing hydrophilic shell and
hydrophobic core in the aqueous phase [40]. Because of natural abundance and desirable
functional properties, significant efforts have been made to explore the application of SPI in
food science, especially the development of bioactive compounds and nutrients delivery
system. Various SPI-based delivery systems have been designed, including hydrogels, edible
film, microspheres, microemulsions and nanoparticles [41-45].

SPI possesses excellent gelling property and both heat-induced and cold-induced
techniques are widely investigated to form SPI-based hydrogels [46, 47]. Particularly, the coldinduced gelation of soy proteins has drawn increasing interest as a novel method to prepare
protein-based hydrogels for nutraceutical delivery. In this process, hydrogels can be achieved
by two steps: preheating of protein solution, which can expose the reactive groups of unfolded
protein globular structure, followed by cooling and adding of cationic ions, like Ca 2+, which
neutralize electrostatic repulsion and form the space-filling hydrogels by building salt bridges
between protein aggregates [48]. Riboflavin has been chosen as a nutraceutical model to
study the bioavailability of SPI hydrogels [46]. The results showed that SPI hydrogels were
able to protect and transport bioactive compounds through gastrointestinal tract and release
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them under intestinal conditions. Recently, the SPI/zein blends microspheres were prepared
and the characterization, swelling behavior and controlled release were comprehensively
studied [49]. The microspheres showed a spherical shape and smooth surface with a particle
size of 15-20 μm. With the blending of zein and SPI, the hydrophobicity and crystallinity of the
protein matrix were modified and the swelling behavior was improved. The release rate of
riboflavin loaded in microsphere was controlled by changing the SPI/zein ratio to have fewer
riboflavin released in the gastric fluid and near-zero-order release in the intestinal fluid. With
this release pattern, the most of the nutrients were able to pass through the stomach and
reached the intestine for maximum absorption. The release of riboflavin from such-prepared
SPI/zein complex microspheres were also tested under fasting and prandial conditions in an
artificial digestive system, as well as in the real food system, yogurt, which further confirmed
its promising potential for use as nutraceutical delivery vehicles in the creation of novel
functional foods [50].

2.2. Polysaccharide-based nanoparticle delivery systems for nutrients

Polysaccharides are the heterogeneous polymers of monosaccharides and are often
referred as abundant naturally-occurring biopolymers. Polysaccharides have a variety of
sources which are usually derived from food origins, including alga, microbes, plants, and
animal products. As raw food-derived biomaterials, they have many unique advantages in that
they are abundant in nature, inexpensive in cost and renewable in production, stable and
hydrophilic in physical properties. Polysaccharides have many functional and reactive groups
which contribute to their diverse chemical and structural composition and confer the excellent
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biological properties, including non-toxicity, biocompatibility, biodegradability, chemical
reactivity, etc. For instance, the hydrophilic groups, such as hydroxyl, carboxyl and amino
groups can form non-covalent bonds with many other biological molecules, such as
glycoprotein in epithelial and mucous membranes, resulting in great mucoadhesive property
for drug and nutrient delivery applications. Generally, polysaccharides can be divided into two
categories, non-polyelectrolyte and polyelectrolyte, and the latter one includes positively and
negatively charged polysaccharides. The polyelectrolyte polysaccharides have wider
applications in terms of formulating nutrient delivery vehicles. With the aid of development of
nanotechnology in recent decades, polysaccharide-based nano-scale delivery systems have
been extensively explored for their applications in food science, biomedicine and
pharmaceutics [51]. Particularly, as a food-derived biomaterial, polysaccharides are receiving
more and more popularity in the fabrication of nano-scale carriers to increase the
bioavailability of poorly-absorbed nutrients, improve the water dispersibility of water-insoluble
bioactive compounds, and enhance the stability and of labile nutrients during food processing,
etc.

2.2.1 Chitosan-based nanoparticles for nutrient delivery

Chitin is a natural and ubiquitous polysaccharide from exoskeleton of invertebrates and
the cell walls of fungi. Chitosan is the N-deacetylation product of chitin. As a linear
polysaccharide, chitosan consists of glucosamine and N-acteyl glucosamine units via β-(1→4)
linkages. The chitosan-based nanoparticles for nutrients delivery does not attract significant
interests until recently. The hydrophilic nutrients, including vitamin C [52, 53], tea polyphenols
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[54-56], selenium [57, 58], natural antioxidant extracts [59], as well as food enzymes [60], have
been encapsulated into chitosan-based nanoparticles. The particle size of nutrients-loaded
chitosan nanoparticles is usually in the range of 100-600 nm, with zeta potential around 2540 mV. Chitosan-based nanoparticles demonstrated promising features in improving the
storage stability under harsh conditions and enhancing bioavailability of such nutrients after
oral administration. For instance, the vitamin C encapsulated in chitosan-based nanoparticles
showed a greater thermal stability during heat processing and a better shelf life [52, 53]. The
intestinal uptake of nutrients encapsulated in chitosan-based nanoparticles has been
evaluated using Caco-2 cell monolayers, the best model to mimic human intestinal absorption
mechanisms, showing that the encapsulation significantly improved the transportation of
nutrients through epithelial monolayer [54]. It is well established that the positive charge of
chitosan-based nanoparticles can open the tight junction by effectively reducing the
transepithelial electrical resistance of the monolayers and can be subsequently uptaken by
Caco-2 cells via an energy-dependent process [61, 62]. This observation was recently
confirmed in animal models, including the mouse and fish, unanimously suggesting that
chitosan-based nanoparticles dramatically enhanced the bioavailability of nutrients by
providing controlled release in GI tract and hence improving the intestinal absorption [53, 55].

Although being a hydrophilic food polymer, chitosan nanoparticles can be used for
encapsulation of hydrophobic nutrients, especially essential oils, when prepared by oil-inwater with the aid of surfactant. Usually, a two-step fabrication method is applied by first mixing
the surfactant (tween 80, for example) with the chitosan solution followed by a particle
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formation step, either via addition of cross-linker such as tripolyphosphate (TPP) or
ultrasonication process [63, 64]. These essential oil-loaded chitosan nanoparticles or
nanoemulsions are generally targeted to enhancing the antimicrobial activities for food safety
applications. Additionally, by complexing chitosan with another anionic biopolymer, either
polysaccharide or protein, it is able to produce more stable polymeric nanoparticles with
enhanced physicochemical properties, including better encapsulation efficiency and slower
release of the nutrients [10]. For instance, various gums have been tested to complex with
chitosan to prepare nanoparticles for encapsulation of essential oils [65, 66]. Chitosan/protein
complex nanoparticles are also being extensively studied recently for their potential to
encapsulate and deliver nutrients. Chitosan/zein complex nanoparticles have been reported
as a promising delivery system for various nutrients, including minerals [58], fat soluble
vitamins [35, 36, 67], lipophilic phytochemicals [38], etc. In such delivery systems, proteins
offer a high affinity to the nutrients for a better encapsulation efficiency, while chitosan provides
strong mucoadhesive property and controlled release profile for excellent delivery efficacy.
Therefore, chitosan-based polymeric complex nanoparticles as delivery systems for nutrients
are proven to have a variety of promising features for future applications in food industry.

2.2.2 Alginate-based nanoparticles for nutrient delivery

Alginate is a water-soluble linear polysaccharide extracted from brown seaweeds and
marine algae, and the commercially available alginate is normally produced from algae only.
Alginate is greatly abundant in nature and the annual industrial production is estimated to be
30,000 metric tons, among which more than 90% alginate is naturally-occurring while less
17

than 10% is biosynthesized. Alginate consists of alternating 1→4 linked β-D-mannuronic acid
(M) and α-L-guluronic acid (G) residues. These two blocks are usually arranged in an irregular
blockwise pattern with varying properties of G-G, M-G, and M-M blocks [10]. Alginate is
classified as GRAS status by FDA, and it has a long history of its wide applications in food
industry as thickener, stabilizer and emulsifier [68].

A few recent efforts are being made to encapsulate and deliver food bioactive compounds
in alginate-based vehicles that may potentially contribute to food industry. Lertsutthiwong and
coworkers reported a three-step procedure, i.e. emulsification, crosslinking with calcium, and
solvent removal, to encapsulate turmeric oil, an essential oil, into alginate nanocapsules [69].
Although the nanocapsules with size smaller than 300 nm were successfully prepared, several
limitations compromise its applications in food industry. For instance, ethanol or acetone was
required during the preparation; the removal of organic solvent caused a significant loss
(>40%) of essential oil; and high concentration of tween 80 was used to emulsify the oil.

2.2.3 Pectin-based nanoparticles for nutrient delivery

Pectin is the major constituent in the cell walls of higher plants and is classified as one of
the most abundant carbohydrates in the nature. Pectin refers to a class of complex
polysaccharides and oligosaccharides with common physicochemical characteristics,
whereas the molecular structure varies with the sources. The chemical structure of pectin
consists mainly of 1,4-linked α-D-galactosyluronic acid residues, with abundant distribution of
the acetyl and methyl esterified carboxyl groups. The most-investigated functionality of pectin
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is the gelling property, which is greatly affected by the degree of methyl esterification and
acetylation. Similar to alginate, the major principle is described by egg box model bridging two
carboxyl groups on two different chains with calcium via ionic linkages and hydrophobic
interactions. However, different mechanisms are involved for gelation of low methyl and high
methyl pectin [70]. As a safe and natural carbohydrate, pectin has been well exploited as a
food additive with no daily limit all over the world. The major uses of pectin in foods include
gelling agent, thickener, texturizer, emulsifier, as well as fat or sugar replacer in low-calorie
foods [71, 72].

Pectin has been studied in recent years to have synergistic effects with other polymers to
form nanoparticles intended for nutrient delivery. Pectin is well-known to adsorb onto protein
nanoparticles to form a core-shell structure. Pectin/𝛽-lactoglobulin and pectin/casein coreshell nanoparticles were reported to have a size between 100-300 nm which formed in the pH
range of 4-6 [73-75]. The adsorption of pectin is triggered by electro-deposition when the pH
is close or lower than isoelectric point of protein molecules and heating is usually required to
induce the partial denaturation protein molecules to form small aggregates or nanoparticles.
Such core-shell nanoparticles have good salt stability at lower pH and are proposed as an
encapsulation and delivery systems for nutrients. Since these particles have similar size and
charge as the lipid droplet found in many food emulsions, they may be used as fat replacers
to mimic the optical, rheological, or sensory properties normally provided by lipid droplets.

2.3. Fabrication methods of chitosan derivatives
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Even though chitosan has been proven to possess a lot of excellent properties, as
mentioned in section 2.2.1, the poor water solubility is the major obstacle limiting its practical
applications. Another limitation of chitosan is that it is not a good chain breaking antioxidant
due to the lack of H-atom donors. In order to overcome the two problems simultaneously,
considerable efforts have been made to modify chitosan. Compared with other polymers, the
modification of chitosan molecules is relatively easy to achieve owing to the abundance of
functional amino and hydroxyl groups [76]. The exploration of fabrication methods to
synthesize chitosan conjugates continues to attract great research interests in the scientiﬁc
community. Thus far, three types of fabrication methods are investigated, including activated
ester-mediated modiﬁcation, enzyme-mediated strategy, and free radical induced grafting
approach.

2.3.1 Activated ester-mediated strategy

Activated ester-mediated modiﬁcation has been adopted in the synthesis of polyphenolchitosan conjugates since last decade. Different cross-linkers have been reported to create
covalent bond between phenolic acid and chitosan. Among those, 1-ethyl-3-(3dimethylaminopropyl) carbodiimide (EDC), a water-soluble coupling reagent, is the most
studied cross-linker that is widely used to initiate covalent linkage between the carboxyl groups
on phenolic acid and the amine groups on the chitosan backbone. This approach has been
used for peptide synthesis and preparation of immunoconjugates [77, 78]. EDC can activate
carboxyl group to form an O-acylisourea intermediate, followed by coupling with primary amine
of chitosan to yield amide bonds [79], as shown in Fig. 2.1A. However, some studies indicated
20

that O-acylisourea intermediate suffered from the risk of hydrolysis and regeneration of
carboxyl group was possible [80]. Later on, it was found that this issue may be solved by
introducing N-hydroxysuccinimide (NHS) to the system, and the possible mechanism is shown
in Fig. 2.1B. In this case, the EDC portion can be replaced by NHS, resulting in the generation
of more stable intermediate active ester [81]. Then the ester further reacts with amino group
on C-2 of pyranose ring of chitosan dissolved in acetic acid to form the amide bond, or react
with hydroxyl group on C-6 of pyranose ring to yield ester bond. Besides, ceric ammonium
nitrate (CAN) was also employed as an initiator for grafting polyphenols onto chitosan. Jung
and colleagues synthesized hydrogels based on eugenol grafted chitosan by using CAN
initiator [82]. The possible mechanism is that the carbon in the vinyl group from eugenol was
covalently bond to the amino group of chitosan, which is shown in Fig. 2.1C.

2.3.2 Enzyme-mediated strategy

Enzyme mediated strategy has been considered to be an eco-friendly procedure to
generate chitosan derivatives. A number of phenolic compounds have been grafted onto
chitosan without harsh acid medium or organic solvent. As illuminated in Fig. 2.2, some
polyphenol oxidases, such as tyrosinase and laccase, are able to convert phenolic compounds
to o-quinones. These highly reactive species can undergo non-enzymatic reaction and
covalently bond to the nucleophilic amine groups of chitosan through either Schiff-base or
Michael-type reaction mechanisms [83]. Meanwhile, the o-quinones can also condense with
each other by the oligomer-forming reactions [84].
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2.3.3 Free radical induced grafting reaction

A new strategy, free radical induced grafting reaction, has been proposed to synthesize
polyphenol-chitosan conjugates in recent years. A hydrogen peroxide (H2O2)/ ascorbic acid
(Vc) pair was employed as redox-inducing system to generate hydroxyl radicals and attack Hatoms of three types of groups on chitosan, including hydroxyl, amino and α-methylene groups,
which result in the formation of macromolecular chitosan radicals. Then polyphenols were
covalently inserted to chitosan radicals on these three positions [85]. Nevertheless, the
specific positions on polyphenols where the conjugation occurs are still unclear. Curcio
hypothesized that the grafting occurred in C-2 and C-5 of the aromatic ring of gallic acid [86],
whereas Liu reported that the carboxyl group of gallic acid was the main position [87].
Therefore, more evidences are still needed to confirm the underlying mechanism of free
radical induced grafting reaction. Compared with traditional activated ester-mediated
modification, there is no toxic reaction product being generated during the fabrication process,
thus enabling a “green” process to prepare chitosan derivatives for food and pharmaceutical
applications.

2.4. Barriers for efficient oral lipophilic bioactive compounds delivery

Numerous lipophilic bioactive compounds, such as curcumin and astaxanthin (ASTX) have
been utilized in nutraceutical, food, feed and pharmaceutical due to their therapeutic effect on
the aging process and chronic diseases. Curcumin, a polyphenolic compound isolated from
dietary spice turmeric, has been proved to possesses anti-inflammatory [88], antioxidant [89],
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anticancer [90], antiproliferative and antiangiogenic activities [91]. However, studies have
shown that curcumin exhibit poor bioavailability in human body, including low plasma and
tissue levels [92]. Major reasons include poor absorption, rapid metabolism, and rapid
systemic elimination. Astaxanthin (ASTX) is a keto-carotenoid that presents in great quantity
in marine animals, such as salmon and shrimp [93]. Studies have shown that ASTX has
antifibrosis effect by preventing the activation of quiescent hepatic stellate cells (HSC) and
reverting the activated HSC to a quiescent state [94]. However, the application is currently
limited due to the low bioavailability, poor water solubility, and instability when exposed to high
temperature, oxygen, light and pH extremes [95, 96].Therefore, to enhance the therapeutic
effect lipophilic bioactive compounds, it is critically needed to develop the nanoparticles
delivery system that is able to improve its physical and chemical stability under harsh
conditions during processing and storage as well as in the GI tract after ingestion.

In order to develop a nano-scale delivery system to administer orally, it is necessary to
have proper understanding about the digestion environment. Significant challenges still
remain for developing effective nanoparticles for oral delivery, due to some physiological
barriers in GI tract, which can be classified as chemical, enzymatic and physical barriers (Fig.
2.3). The first challenge for nanoparticles is the stability over a wide range of pH variation in
GI tract. Nanoparticles reach stomach from mouth in less than one minute where they
encounter a sudden reduction in pH from 6.8 to 1.2, followed by transition from highly acidic
environment to slightly basic environment (pH 6.5 to 8.0) in small intestine [97]. The mean
transit time in stomach and residence time in small intestine is around 2.5 h and 3-4 h,
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respectively [98]. Studies have shown that the dissociation of nanoparticulate structure could
happen due to the deprotonation or protonation of particle components (such as
polysaccharides, proteins or lipids) in different pH environment, resulting in the burst release
and degradation of encapsulated bioactive compounds [99, 100]. Apart from the harsh acidic
condition in stomach, the enzymatic degradation is another challenge for oral delivery. The
susceptibility of nanoparticles to various digestive enzymes in GI tract poses a major obstacle
to achieving desired efficacy for oral delivery. The decomposition of lipid- and protein- based
nanoparticles begins in the stomach by gastric lipase and pepsin, respectively [101, 102]. The
degradation continues in small intestinal lumen by pancreatic enzymes, including lipase,
trypsin, α-chymotrypsin, elastase, and carboxypeptidases A and B [103]. Even though the
decomposition of polysaccharide-based nanoparticles does not happen in stomach, their
nanostructure may disassemble due to weakened electrostatic interactions with other
polyelectrolytes. After nanoparticles overcome the chemical and enzymatic degradation and
successfully transit to the intestinal lumen, they will be exposed to the intestinal epithelium
layer covering the surface of the GI tract, which is a collection of enterocytes, goblet cells,
Paneth cells and microfold cells, constituting another major barrier before absorption [104].
Goblet cells are able to produce a mucus layer that covers and protects the underlying
epithelium [105]. The mucus layer is a negatively charged viscous mixture containing mucins,
antiseptic enzymes, immunoglobulins and inorganic salts, and thus it is capable to trap
nanoparticles possessing strong positive charge and hydrophobic nature in surface properties
[106, 107]. It was suggested that nanoparticles with electrically neutral and hydrophilic surface
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are ideal for mucus permeation [108, 109]. Two absorption mechanism by which nanoparticles
across epitheliums and enter systemic circulation after the diffusion through mucus layer have
been reported, including transcellular and paracellular pathways [110]. The paracellular
pathway involves the passage of nanoparticles through the space between epithelial cells
[111]. Tight junctions (TJs) structure is formed to strengthen the cell lining by holding epithelial
cells tightly connected to one another. It has been reported that the pore radius of TJs is only
5 nm, which restricts the permeation of large size foreign particles even with strong hydrophilic
nature [112]. Nevertheless, the reversible opening of TJs could occur by different mechanisms,
such as decreasing of calcium ion concentration, modifications of the cytoskeletal organization,
and down-regulation of TJs protein [113, 114]. Another absorption mechanism is transcellular
pathway that involves either passive transport or endocytosis of nanoparticles through
epithelial cells. The cut-off size of nanoparticles that could be uptaken by epithelial cells has
been reported to be 300 nm [115]. Apart from particle size, the surface properties also play a
vital role in absorption of nanoparticles through transcellular pathway. It is known that
nanoparticles with positive charge and hydrophobic surface properties are ideal for the high
interaction with negatively charged epithelial cell membrane, which is in contradiction to mucus
permeation theory [116]. Therefore, more research efforts should focus on development of
nanoparticles delivery systems for lipophilic bioactive compounds oral delivery to overcome
the barriers in GI tract and improve their bioavailability.
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2.5. Figures and tables
Figure 2.1 Proposed mechanism for synthesis of polyphenol-chitosan conjugate using (A)
EDC; (B) EDC/NHS; (C) CAN.
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Figure 2.2 Proposed mechanism for synthesis of polyphenol-chitosan conjugate through
enzyme-mediated strategy.
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Figure 2.3 The segments of GI tract and barriers for efficient oral insulin delivery.
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Chapter 3
Characterization of gallic acid-chitosan conjugate
prepared by free radical induced grafting reaction

Part of this chapter, including tables and figures, has been published in Journal of
Agricultural and Food Chemistry, 2016, 64 (29), 5893-5900 and reprinted with permission
from American Chemical Society
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3.1. Background

Polyphenol is a group of secondary metabolites from plants which play vital roles in growth,
reproduction, pigmentation and defense mechanism of ultraviolet radiation and pathogens
[117, 118]. More importantly, polyphenols are considered as natural antioxidant and widely
employed in foods, drugs, and cosmetics. Therefore, water soluble chitosan-based conjugate
with prominent antioxidant activity can be obtained by grafting various polyphenols, for
instance, gallic acid [119], caffeic acid [120], ferulic acid [121], salicylic acid [122], and eugenol
[82] onto chitosan backbone. Gallic acid (GA), also known as 3, 4, 5-trihydroxybenzoic acid,
is a natural phenolic acid widely distributed in the plant kingdom, especially green tea. The
GA grafted chitosan conjugate (GA-CS) has been synthesized via many methods, such as
activated ester [123], enzyme catalyzed polymerization [124]. Particularly, the free radical
induced grafting approach has been previously reported to successfully synthesize GA-CS
with potential to prevent oxidative stress in cell models [125, 126]. However, as a new and
novel fabrication approach, the preparation method and physicochemical properties of asprepared GA-CS have not been systematically studied.

The objective of this study was to prepare, characterize, and investigate the antioxidant
activity of GA-CS prepared by free radical induced grafting approach, as a green and facile
process using ascorbic acid (Vc)/hydrogen peroxide (H2O2) redox pair. The effects of mass
ratio between GA and chitosan on the grafting degree was studied in detail, and the obtained
GA-CS was characterized by Fourier transform Infrared (FT-IR), UV-vis, X-ray diffraction
(XRD), pKa and scanning electron microscopy (SEM) analyses. Finally, the antioxidant activity
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of GA-CS was evaluated by various in vitro chemical-based assays and compared with native
chitosan and GA.

3.2. Experimental design

3.2.1. Preparation of GA-CS

The GA-CS was synthesized according to the ascorbic acid/hydrogen peroxide redox pair
method with some modifications [86]. Briefly, the stock solution of chitosan (10 mg/mL) was
prepared by dissolving in 2% acetic acid (v/v). To prepare GA-CS, 1 mL of 1.0 M H2O2
containing 0.054 g of ascorbic acid was added into 50 mL of chitosan solution and stirred for
30 min. Then, different amount of GA (the mass ratio of GA to chitosan: 0.1:1, 0.25:1, 0.5:1,
1:1, and 2:1) was introduced into the above mixture and the reaction was carried out at room
temperature for 24 h. Afterwards, the mixture was poured into dialysis bags (MWCO 10,000
Da) and dialyzed against deionized water for 48 h with changes of water every 8 h to remove
unreacted GA. Finally, the resulting solution was lyophilized using FreeZone Console Freeze
Dry System (Labconco, Kansas City, MO, USA) to obtain water soluble GA-CS solid samples.

3.2.2. Determination of grafting degree of GA-CS

The measurement of GA content in GA-CS was carried out according to the Folin–
Ciocalteu method with slight modification [127]. Briefly, the freeze-dried GA-CS powder was
dissolved in deionized water at 1 mg/mL. Then, 0.5 mL of each sample was mixed with 1 mL
of Folin–Ciocalteu reagent (10 times dilution) and reacted for 5 min in the dark, followed by
the addition of 2 mL 15% Na2CO3 and deionized water till 10 mL. The mixture was shaken and
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maintained under room temperature for 2 h and the absorbance of the reaction mixture was
read at 750 nm using UV-vis spectrophotometer (Evolution 201, Thermo Fisher Scientific Inc.,
Waltham, MA, USA). GA was used as a standard and the grafting degrees of GA-CS were
expressed as mg of GA equivalents per g (mg GAE/g) of GA-CS.

3.2.3. Characterization of GA-CS

The FT-IR spectra of chitosan, GA-CS and GA were recorded on a Fisher Scientific Nicolet
Is5 Spectrometer equipped with an iD7 ATR accessory (Thermo Fischer Scientific Inc.,
Waltham, MA) by scanning from 4000 – 500 cm-1 at a resolution of 4 cm-1 and analyzed using
OMNIC software version 8.0.

The UV-vis spectra were determined by a UV-vis spectrophotometer (Evolution 201,
Thermo Fisher Scientific Inc., Waltham, MA, USA) by scanning from 200 to 750 nm.

In order to investigate the crystallographic structures of chitosan and GA-CS, the powder
XRD spectra was acquired from 2θ = 5-75o on a Rigaku Ultima IV X-ray diffractometer using
Cu Kα radiation operating at 40 Kv and 44 Ma.

The optimal GA-CS with the highest GA grafting degree was used for the pKa
measurement. Briefly, 10 mg of GA-CS powder was dissolved in deionized water at
concentration of 1 mg/mL and adjusted into different pH (4.0 – 11.0). The zeta potential of
each sample was determined by laser Doppler microelectrophoresis technology using a Nano
Zetasizer ZS (Malvern Instruments, Ltd., Worcestershire, UK).

3.2.4. Morphological properties of GA-CS
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The morphology of freeze-dried GA-CS powder was observed under scanning electron
microscopy (SEM). The control was prepared following the same procedures described in
Section 3.2.1 but in the absence of ascorbic acid, hydrogen peroxide and GA. Samples were
deposited onto double adhesive carbon conductive tape before observed under SEM (JSM6330F, JEOL Ltd., Tokyo, Japan).

3.2.5. Assay of antioxidant activity in vitro

The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity was assayed
according to the method of Dudonne with slight modifications [128]. Chitosan, GA-CS and GA
were dissolved in deionized water for preparation of a serious of concentration (0.05, 0.1, 0.2,
0.4, 0.6, 0.8, 1.0 mg/mL). Then, 200 µL of DPPH solution (0.4 mM DPPH in methanol) was
mixed with 50 µL of each sample in a 96-well microplate. The mixture was shaken vigorously
and allowed to stand in the dark at room temperature for 30 min and the absorbance was
measured at 517 nm using a microplate reader (BioTek Instruments, Inc., Winooski, VT, USA).
The control was prepared by replacing sample with deionized water, and meanwhile the
sample background (sample added in methanol without DPPH) was also measured to avoid
any interference of background color.

DPPH free radical scavenging activity (%) = (1 −

𝐴𝑠 − 𝐴𝑏
) × 100
𝐴𝑐

Where As, Ab, and Ac are the absorbance of the sample, background, and control, respectively.
The concentration of the samples that caused 50% inhibition of DPPH radical (IC50) was
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calculated from the graph of radicals scavenging activity percentage against sample
concentration.

The spectrophotometric analysis of 2,2'-azino-bis(3-ethylbenzothiazoline-6)-sulphonic
acid (ABTS) radical scavenging activity was carried out in 96-well microplate according to the
method of Xie et al. [129] with modifications. Briefly, 7 mM ABTS aqueous solution was
reacted with 4.95 mM potassium persulfate and the mixture was stored in the dark at room
temperature for 12 h to generate ABTS free radicals. Then, the ABTS was diluted with sodium
phosphate buffer (PBS 0.2 M, pH 7.4) to a concentration that the absorbance at 734 nm was
0.7 ± 0.02 to provide a working solution before usage. The absorbance of a mixture of 200 µL
ABTS working solution and 20 µL of each sample was monitored at 734 nm. The control was
prepared by replacing sample with deionized water, and meanwhile the sample background
(sample added in PBS without ABTS) was also measured to avoid any interference of
background color.

ABTS free radical scavenging activity (%) = (1 −

𝐴𝑠 − 𝐴𝑏
) × 100
𝐴𝑐

Where As, Ab, and Ac are the absorbance of the sample, background, and control, respectively.
The concentration of the sample that caused 50% inhibition of ABTS radical (IC50) was
calculated from the graph of radicals scavenging activity percentage against sample
concentration.

The reducing power of chitosan, GA-CS and GA was determined following a previous
report with some modifications [130]. The reaction was carried out in a mixture containing 50
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µL of each sample (1mg/mL), 50 µL of PBS (0.2 M, pH 6.6), and 30 µL of K3Fe(CN)6 (1%, w/v)
and was incubated in 96-well microplate at 50 oC for 20 min. After addition of 30 µL of FeCl3
(0.1%, w/v) and 50 µL of trichloroacetic acid (10%, w/v), the absorbance of the mixture was
measured at 700 nm, and the higher absorbance indicated a higher reducing power. The
control was prepared by replacing FeCl3 with deionized water.

Reducing power = 𝐴𝑐 − 𝐴𝑠
Where As and Ac are the absorbance of sample and control, respectively. The concentration
of the sample that provided 0.5 of absorbance (IC50) was calculated.

The antioxidant capacity of chitosan, GA-CS and GA were also determined by the Oxygen
radical antioxidant capacity assay (ORAC) assay, as reported by Zulueta et al [131]. It was
evaluated by scavenging peroxide radicals that were generated by 2,2'-Azobis(2amidinopropane) dihydrochloride (AAPH), preventing the loss of fluorescence of the probe.
The reaction was carried out in 96-well microplate and each well contained 20 µL of sample
(5 μg/mL)/blank (phosphate buffer solution, pH 7.4)/standard (8 μM), and 120 µL fluorescein
(70 nM). The mixture was allowed to stay at 37 oC for 15 min, followed by addition of 60 µL
AAPH (12 mM) in PBS solution (pH 7.4). The fluorescence of the mixture was recorded every
1 min for 80 min at excitation and emission wavelengths of 485 and 520 nm, respectively. The
ORAC values of samples were expressed as μM Trolox equivalents (μM TE).
ORAC (μM TE)=

𝐶𝑡 ×(𝐴𝑈𝐶𝑠 −𝐴𝑈𝐶𝑏 )×𝑘
(𝐴𝑈𝐶𝑡 −𝐴𝑈𝐶𝑏 )
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Where Ct is the concentration of trolox (8 μM), k is the sample dilution factor, and the AUC is
the area below the fluorescence decay curve of the sample (AUCs), blank (AUCb), and trolox
(AUCt) that were calculated from the following equation:
𝑖=80

AUC = 1 + ∑
𝑖=1

𝑓𝑖
𝑓0

Where f0 is the initial fluorescence and fi is the fluorescence at time i.

3.2.5. Stability of GA-CS

The stability of GA-CS was studied by measuring the total phenol content using UV-vis
spectrophotometer (Evolution 201, Thermo Fisher Scientific Inc., Waltham, MA, USA)
compared with GA, as a function of storage time. The GA-CS freeze-dried powder and GA
were dissolved in deionized water at a concentration of 1.0 mg/mL and stored at refrigeration
condition (4 oC) for up to 14 days. At each time point, samples were subjected to the phenolic
content measurement.

3.3. Results and discussion

3.3.1. Optimization of grafting degree

The antioxidant activity of chitosan-based conjugates strongly depends on the amount of
grafted antioxidant molecules on the chitosan backbone [121, 132]. Therefore, in order to
synthesize the optimal GA-CS and investigate its physicochemical properties, the conjugates
with different mass ratio of chitosan to GA (0.1:1, 0.25:1, 0.5:1, 1:1, and 2:1) were prepared
and the grafting degree were evaluated by measuring GA content and zeta potential. As
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shown in Fig. 3.1A, the grafting degree significantly increased as the increase of mass ratio
up to 0.5:1, followed by a subsequent decrease when the mass ratio reached to 1:1 and 2:1.
In this study, the number of macromolecular chitosan radicals induced by the constant
concentration of Vc/H2O2 initiator was the same in different samples. Therefore, the
enhancement of grafting degree was due to the increasing of GA ratio within the critical range.
However, beyond that range, the excess amount of free GA molecules may inhibit grafting
process causing a reduction of grafting degree. This observation was also reported in a
previous study [87], showing the highest grafting degree (88.53 mg GAE/g GA-g-chitosan)
was obtained when the mass ratio of GA to chitosan was 0.5:1.

Zeta potential of the conjugates with different mass ratio of GA to chitosan is shown in Fig.
3.1B. It is widely used to quantify the magnitude of the charge in dispersion medium. The
change of zeta potential exhibited an opposite trend with grafting degree as affected by the
mass ratio of GA to chitosan. Due to the abundant protonated amino groups on its backbone,
the native chitosan exhibited a very high magnitude of positive charge (64.2 mV) in acidic
condition. On the contrary, the GA-CS showed much smaller magnitude of positive charge in
the range of 26.3-33.6 mV, and the higher grafting degree resulted in a less positive charge.
This significant reduction in zeta potential may be explained by the less available protonated
amino groups due to the formation of peptide bond with GA. The lowest zeta potential was
observed when the grafting degree at the GA/chitosan ratio of 0.5:1, confirming the highest
grafting degree. Therefore, the GA-CS with a mass ratio of GA to chitosan 0.5:1 was chosen
as the optimal sample for subsequent characterizations.
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3.3.2. Characterization of GA-CS

The FT-IR spectra of chitosan, GA-CS powder, and GA are shown in Fig. 3.2A to identify
their molecular interactions. The spectrum of GA showed strong absorbance bands at 3491
and 3269 cm-1 which attributed to –OH stretching on benzene ring, as well as several peaks
within 1450-1600 cm-1 representing the aromatic ring C=C stretching [133]. Several typical
peaks of amide bonds were observed in the chitosan spectrum, i.e. the absorbance bands at
1651, 1550, and 1316 cm-1, corresponding to C=O stretching (amide I), N–H bending (amide
II) and C–N stretching (amide III), respectively [134]. There was an absorbance peak at 1589
cm-1, corresponding to N–H bending of the primary amine [135]. Besides, the saccharide
structure of chitosan was characterized by the asymmetric stretching of C–O–C bridge at 1150
cm-1 and C–O stretching at 1060 and 1024 cm-1 [136]. Compared to chitosan, the absorbance
of N–H bending of the primary amine at 1589 cm-1 was not observed in GA-CS, indicating that
conjugation reactions occurred at -NH2 sites on chitosan backbone. Furthermore, the
absorbance peaks of C=O stretching and N–H bending shifted from 1651 and 1550 to 1631
and 1531 cm-1, respectively, and became stronger in GA-CS, suggesting the formation of NH–
CO group [137]. In addition, a new vibration peak at 1731 cm-1 was observed in GA-CS due
to the C=C stretching in esters, representing the formation of ester bond between the carboxyl
groups of GA and hydroxyl groups of chitosan. The FT-IR results further proved that the
conjugation of GA occurred at both amino and hydroxyl groups of chitosan.

The UV-vis spectra of chitosan, GA-CS and GA were shown in Fig. 3.2B. Chitosan showed
no absorption peak ranging from 200 to 750 nm, while GA exhibited one characteristic
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absorption band at 211 nm and another band at 259 nm, which were assigned to the π-system
of the benzene ring [129]. These two characteristics peaks were observed in GA-CS,
confirming the successful conjugation. In addition, a slight red shift of UV-vis absorption peak
from 259 nm to 261 nm was observed in the spectrum of GA-CS, attributing to the lower
energy required for the n–π* and π–π* transition due to the formation of the covalent linkage
between chitosan and GA [86].

The crystallographic structures of chitosan, GA-CS and GA samples were determined by
XRD. As presented in Fig. 3.2C, two strong peaks were observed in the diffractogram of native
chitosan at 2θ = 10.62 o and 20.11 o, pointing out high crystallinity of chitosan [138]. However,
the peaks of GA-CS were shifted to 12.52 o and 23.29 o, respectively. In addition, the peaks
became broader and weaker, indicating the looseness in packing of chitosan caused by
successful introduction of GA. The XRD result revealed that in GA-CS, the intensity of interand intramolecular hydrogen bonds was significantly reduced, resulting in remarkable
decrease in the crystallinity. Therefore, the water solubility of GA-CS was significantly
increased compared with native chitosan. Similar results were also reported in previous
studies that conjugation of phenolic acids to chitosan induced the increase of amorphous
phase and looseness of chain packing [119, 123].

The zeta potential and appearance of conjugate with different pH values were shown in
Fig. 3.2D. The freeze-dried GA-CS was able to directly dissolve in deionized water with a pH
of 5.5. The change of zeta potential of GA-CS was inversely proportional to the pH change.
At acidic range of pH values (4.0–7.0), the GA-CS exhibited a high transparency and the zeta
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potential gradually decreased from 29.9 to 5.37 mV. At pH 8.0, precipitation was observed in
GA-CS and the color changed to yellow. Meanwhile, the zeta potential decreased to 1.26 mV,
which is close to 0 representing the pKa value of GA-CS. Subsequently, with further increase
in pH, the GA-CS solution turned opaque with dark green color and severe precipitation. This
phenomenon can be explained by the oxidation of GA and formation of polymerized
compounds of o-quinone derivatives which was facilitated by alkalinization, resulting in green
coloration of the medium [139].

In summary, the GA has been successfully grafted on CS, which was evidenced by the
results mentioned above. The possible mechanism for the preparation of GA-CS was
illustrated in Fig. 3.3.

3.3.3. Morphological properties of GA-CS

The surface morphology of freeze-dried chitosan and GA-CS was observed under SEM,
shown in Fig. 3.4. There were several differences between these two samples. The freezedried chitosan appeared to be highly packing structural flakes with smooth surface and fiberlike structure on the edge, owing to the strong inter- and intramolecular hydrogen bonds.
Although freeze dried GA-CS also exhibited the flake-like morphology, it was distinct from that
of chitosan in the following points. Firstly, the fiber-like edge was not observed on freeze dried
GA-CS. Secondly, compared to the dense chitosan flake, the surface of freeze-dried GA-CS
was rough and porous, indicating the greatly decreased hydrogen bonds and the reduction of
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crystallinity during the grafting process. This result was in accordance to the previous studies
[140, 141].

3.3.4. Antioxidant activity of GA-CS

DPPH, a stable organic free radical, has been widely used to evaluate the antioxidant
activity of various samples. The DPPH scavenging abilities of chitosan, GA-CS and GA are
shown in Fig. 3.5A. With the increase of chitosan concentration in the range of 0.05 to 1.0
mg/mL, chitosan showed a slightly increased trend of scavenging activity but the highest value
was only 19.63%. As a natural antioxidant molecule, GA showed excellent DPPH free radical
scavenging activity at concentrations as low as 0.05 mg/mL which was significantly greater
than that of GA-CS and chitosan. The scavenging activity of GA-CS significantly increased as
the increase of concentration up to 0.4 mg/mL and reached its plateau at 0.6 mg/mL with the
highest scavenging activity of 94.5%, which was the same as the free GA molecule. The IC50
values for chitosan, GA-CS and GA against DPPH radicals were 4.299, 0.196 and 0.045
mg/mL, respectively. It has been reported that the DPPH scavenging activities were positively
correlated with polyphenol contents in the chitosan-based conjugates [132]. By comparing to
other phenolic acid-chitosan conjugate synthesized using the same method, which had 74.54%
DPPH scavenging activity with a 45.8 mg GAE/g of grafting degree [134], the GA-CS in the
present study showed both greater grafting degree and superior DPPH scavenging activity.

The ABTS assay has been widely applied for testing the preliminary free radicals
scavenging ability of antioxidant compounds. Nevertheless, the scavenging capacity of GA-
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CS synthesized by the Vc/H2O2 redox pair has not been reported. As shown in Fig. 3.5B, our
results revealed that the scavenging capacity against ABTS radicals of all samples, including
chitosan, GA-CS and GA shared similar trends with those against DPPH. The scavenging
activity of chitosan increased slowly with the increase of concentration. At the concentration
range from 0.05-0.2 mg/mL, the scavenging activity of GA-CS dramatically increased. It is
notable that the scavenging activity of GA-CS increased rapidly and reached it plateau at 0.4
mg/mL (99.49%), which was even slightly higher than that of GA control (99.1%), which might
be explained by the synergistic reaction between chitosan and GA in the conjugate. The IC50
values for chitosan, GA-CS and GA were 3.526, 0.076 and 0.003 mg/mL, respectively. Yu et
al. prepared GA grafted carboxymethyl chitosan conjugate via EDC/NHS modification method
and reported that the IC50 is 0.291 mg/mL [142]. The comparison indicated that the GA-CS
prepared by free radical induced grafting method had superior ABTS radical scavenging
activity than that synthesized by activated ester-mediated approach. The ABTS radical
scavenging activity of as-prepared GA-CS is also dramatically higher than other polyphenolic
acid conjugates, such as ferulic acid [143] which was reported to have a IC50 of 0.20 ± 0.02
mg/mL. This may be ascribed to the fact that GA contains more phenolic hydroxyl groups than
ferulic acid does, and phenolic hydroxyl groups are known to play an important role in the
hydrogen and electron donating ability.

Reducing power may act as a significant indicator of the antioxidant activity. It is based on
the reduction of Fe3+ to Fe2+ by antioxidant agent, followed by the formation of ferric-ferrous
complex which has a maximum absorption at 700 nm. As shown in Fig. 3.5C, native chitosan
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showed negligible reducing powder at all concentrations tested in this study, while GA-CS
showed gradually increased reducing powder as increase of concentration and eventually
reached similar capacity with free GA. At the concentration of 1.0 mg/mL, the reducing power
of chitosan, GA-CS and GA were 0.009, 2.660 and 2.849, respectively. The IC50 values of
chitosan, GA-CS and GA were 79.365, 0.067 and 0.010, respectively. Like the scavenging
activity against DPPH and ABTS radicals, it is worth mentioning that the reducing of GA-CS
in our study is also much higher that other phenolic acids-chitosan conjugates reported in
previous studies [132, 134].

The ORAC method has been widely adopted to evaluate the antioxidant activity of foods
and active compounds [144]. However, to our best knowledge, the ORAC assay among
modified chitosan, especially the polyphenol-chitosan conjugates, was rarely reported. In fact,
the ORAC value of GA-grafted-chitosan has only been published in one study [145]. The GACS, prepared using EDC/NHS chemical cross-linker with a grafting degree of 58.1 ± 1.2 mg
GAE/g, exhibited a 19-fold higher ORAC value than native chitosan. In our study, the GA-CS
showed an enhanced capacity to scavenge peroxyl radicals with an ORAC value 1.83 folds
higher than native chitosan. The ORAC values of chitosan, GA-CS and GA were 1117.2 ±
145.8, 2043.7 ± 352.0, and 2843.8 ± 335.0, respectively (Fig. 3.5D).

3.3.5. Stability of GA-CS

The free radical-initiating reaction is sensitive to oxygen in the condition, resulting in the
degradation of GA and the decrease of GA contents in chitosan conjugate [87]. Meanwhile,
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the stability of GA-CS is also greatly affected by temperature that higher temperature may
induce faster degradation of GA in the conjugate [146].Therefore, the evaluation of the stability
is critical to explore the applications of GA-CS. In the present work, the stability of GA-CS was
tested under refrigeration (4 ºC) condition, by monitoring the total phenol content at designated
time points (Fig. 3.6). For both GA-CS and GA, the total phenol content gradually decreased
as the extension of storage time and reached to 90.9% and 87.2% at day 14, respectively,
owing to the degradation of GA.

3.4. Conclusion

In the present study, GA-CS was successfully prepared using free radical induced grafting
approach. The grafting of GA was confirmed by FT-IR and UV-vis, suggesting that the grafting
reactions occurred between amino and hydroxyl groups of chitosan and carboxyl groups of
GA. The result of XRD analyses indicated that the enhanced water solubility of GA-CS may
be attributed to the decrease in crystallinity, which was further evidenced by the morphological
observation. The mass ratio of 0.5:1 between GA and CS was considered as the optimal ratio
by determining the grafting degree and zeta potential. In addition, GA-CS exhibited excellent
reducing power, ORAC value and scavenging capacities against DPPH and ABTS free
radicals which were all superior to native CS.
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3.5. Figures and tables
Figure 3.1 Effects of different mass ratio of gallic (GA) and chitosan (CS) on the (A) grafting
degree and (B) zeta potential of gallic acid-chitosan conjugate (GA-CS). The values sharing
different superscript letters were statistically different at p<0.05.
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Figure 3.2 Characteristics of chitosan (CS), gallic acid-chitosan conjugate (GA-CS) and gallic
acid (GA): (A) FT-IR spectra of CS, GA-CS and GA; (B) UV-vis spectra of CS, GA-CS and GA;
(C) XRD patterns of CS and GA-CS; (D) Zeta potential and appearances of GA-CS with
different pH values.
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Figure 3.3 Proposed mechanism for the fabrication of gallic acid-chitosan conjugate through
free radical induced grafting reaction.
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Fig. 3.4 SEM images of native chitosan and GA-CS. (A) Native chitosan; (B) GA-CS. Scale
bars are 100 μm.
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Fig. 3.5 Scavenging activities against (A) DPPH radical and (B) ABTS radical, as well as (C)
reducing power and (D) oxygen radical antioxidant capacity of chitosan (CS), gallic acidchitosan conjugate (GA-CS), and gallic acid (GA). Data are presented as means ± SD of
triplicates.
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Fig. 3.6 Stability of gallic acid-chitosan conjugate (GA-CS) and GA at 4 oC
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Chapter 4
Selection and modification of biopolymers

Part of this chapter, including tables and figures, has been published in Food Hydrocolloids,
2018, 89, 386-395 and reprinted with permission from Elsevier
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4.1. Background

Even though the GA-CS was successfully prepared, it may not be suitable as a good
candidate to prepare nanoparticles for lipophilic bioactive compounds. The major reason is
that the stability of as-prepared chitosan derivative was poor, caused by degradation of GA.
In addition, the viscosity and molecular weight of GA-CS was significantly lower than native
CS, indicating the strong water-solubility. However, it might weaken the interaction between
GA-CS and lipophilic compounds during the fabrication of nanoparticles. Therefore, more
effort should focus on preparing amphiphilic CS derivative using the green synthesis method.
The modification of CS is necessary to increase the amphiphilicity, and grafting a long-chain
fatty acid is a common approach to add a hydrophobic moiety to CS chain, thus achieving
amphiphilicity. In this study, stearic acid-chitosan conjugate (SA-CS) was prepared via the
free radical grafting method [9]. As the unique cationic polysaccharide, CS is able to interact
with polyanions leading to the spontaneous formation of nanoparticles, which process is
generally referred as ionic gelation or polyelectrolyte complexation method. As discussed in
section 2.1.1, sodium caseinate (NaCas) is the most common form of casein which is found
in mammalian milk [147]. Due to its amphiphilicity and high affinity to both hydrophobic and
hydrophilic compounds, NaCas has been widely used as nutrients/drugs carrier. However, as
a protein molecule, the acidic environment and enzymatic digestion in stomach leads to the
denaturation of NaCas, resulting in the dissociation of its nanostructure [148]. Hence,
amphiphilic SA-CS coating is needed to ensure the integrity of its nanostructure during gastric
digestion.
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Nevertheless, the pKa value of amino groups on SA-CS has been known as 5.0, which
means that in small intestine (where the neutral pH is close to the pKa value), the protonation
level becomes minimal and so severe aggregation occurs [149]. Thus, it is necessary to exploit
other mechanisms to further stabilize SA-CS/NaCas nanoparticles against aggregation and
enzymatic degradation in the small intestine condition. The periodate oxidized dextran (Oxdex)
with two aldehyde groups has been demonstrated to possess the similar reaction mechanism
as glutaraldehyde and been applied as a macromolecular cross-linker to stabilize SACS/sodium caseinate polyelectrolyte complex nanoparticles under neutral condition by
creating covalent bonds between the two components [150-152].

4.2. Experimental design

4.2.1. Preparation and characterization of SA-CS

SA-CS was synthesized according to the ascorbic acid/hydrogen peroxide redox pair
method with some modifications [153]. Briefly, CS was dissolved in acetic acid at 10 mg/mL.
The stock solution of SA (0.1 mg/mL) was prepared by dissolving it in pure ethanol and
followed by ultrasonication until SA was completely dissolved. To prepare SA-CS, 1 mL of 1.0
M H2O2 containing 54 mg of ascorbic acid was added into 50 mL of CS stock solution and
stirred for 30 min, followed by adding 50 mL of SA stock solution. The reaction was carried
out at room temperature for 24 h. Then, the mixture was heated at 70 °C for 6 h with stirring
to evaporate ethanol. Afterwards, the mixture was dialyzed against 50% ethanol for 48 h with
changes of water every 8 h to remove unreacted SA. Finally, the resulting solution was
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lyophilized using FreeZone Console Freeze Dry System (Labconco, Kansas City, MO, USA)
to obtain SA-CS dry powders.

The FT-IR spectra of CS, physical mixture of SA and CS, SA-CS and SA were recorded
on a Fisher Scientific Nicolet Is5 Spectrometer equipped with an iD7 ATR accessory (Thermo
Fischer Scientific Inc., Waltham, MA, USA) by scanning from 4000-500 cm-1 at a resolution of
4 cm-1 and analyzed using OMNIC software version 8.0. The presence of stearic acid in the
SA-CS was confirmed using nuclear magnetic resonance spectroscopy (NMR). 1H NMR
spectra were recorded with native CS dissolved in CD3COOD/D2O (v/v, 1%) and SA-CS
dissolved in D2O by using AVANCE 300 MHz NMR Spectrometer. The degree of substitution
(DS) of SA-CS was defined as the number of methyl groups per 100 sugar residues of chitosan,
was calculated by 1H NMR using the ratio of methyl protons (δ = 1.0-1.1 ppm) to H-2 protons
(δ = 3.1 ppm) of CS [154].

4.2.2. Preparation and characterization of Oxdex

The synthesis of Oxdex was carried out according to the method of Weng et al [155] with
minor modifications. Oxdex was prepared by first dissolving 1.65 g of dextran in 50 mL of
deionized water (DI water), followed by adding 3.85 g of sodium periodate. The mixture was
stirred at room temperature for 1.5 h, and then dialyzed for 10 h using a dialysis tube with a
molecular weight cut-off (MWCO) of 12,000-14,000 Da. Finally, the resulting solution was
lyophilized to obtain Oxdex dry powders.

4.3. Results and discussion
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4.3.1. Preparation and characterization of SA-CS

Amphiphilic CS has been commonly prepared by grafting a hydrophobic moiety, i.e.,
aliphatic acid or fatty acid through N-acylation [156], or amidation reaction [157], respectively.
Owing to the amphiphilic property, modified CS often possesses better dispersibility in neutral
water and may have self-assembly capability to form micellar structure, which creates a strong
non-polar microenvironment for improving the encapsulation efficiency for hydrophobic
bioactives. Meanwhile, the amphiphilic CS could interact with other biopolymers through
enhanced hydrophobic interactions, especially with proteins when they are reacting under the
specific condition to form nanoparticles. Hu and colleagues synthesized SA-CS
oligosaccharide using EDC chemical modification and indicated this amphiphilic CS could selfaggregate to form micelles [157]. In the present study, a free-radical induced grafting method
was adopted to prepare SA-CS conjugate. Based on the possible mechanism (as shown in
Fig. 4.1A) which was elaborated by Curcio [158], the hydrogen atoms from amino groups and
hydroxyl groups on CS were abstracted by hydroxyl free radicals generated from oxidization
between ascorbic acid and hydrogen peroxide, resulting in the formation of macromolecular
CS radicals. Then, the carboxyl groups on SA act as an acceptor for macromolecular CS
radicals and react with amino groups and hydroxyl groups of CS to form peptide bonds and
ester bonds, respectively. This method showed several advantages compared with other
chemical modifications, such as no toxic byproducts generation, low energy consumption and
low cost. The free-dried SA-CS sample can easily dissolve in water at 2 mg/mL with relatively
high positive surface charge (zeta potential = +42.5 mV), although significantly lower than
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native CS (+64.2 mV). It is notable that SA-CS became less viscous compared to native CS.
Therefore, it is deduced that partial degradation of CS backbone may occur and its molecular
weight may be significantly reduced which could be due to the presence of hydrogen peroxide
during conjugation process. The reduced protonation level could be explained by the
consumption of amino groups during the formation of peptide bonds with stearic acid.

The successful preparation of SA-CS with 8.4% DS was evidenced by FT-IR and NMR
results (Fig. 4.1B and C). The spectra of CS, physical mixture of SA and CS, SA-CS and SA
(Fig. 4.1B) were compared to show the intermolecular interactions. Three characteristic peaks
of CS at 1533, 1626, and 1315 cm-1 represented the primary amine (N–H bending), amide I
(C=O stretching), and amide III (C–N stretching), respectively [135, 159]. In the spectrum of
SA-CS, the stronger amide I absorbance at 1617 cm-1 suggested the formation of new peptide
bonds [137]. In addition, the appearance of new vibration peak at 1692 cm-1 corresponding to
C=O stretching indicated the formation of ester bonds [153]. However, there is no difference
between spectra of SA and CS physical mixture and CS, suggesting that the conjugation
between CS and SA did not occur by mixing two solutions together. The invisibility of SA peaks
in the physical mixture could be attributed to the extremely low ratio of SA in the mixture, i.e.
SA:CS at 1:100. These observations, therefore, well agreed with the proposed reaction
mechanism (Fig. 4.1A). The structure of SA-CS was further confirmed by 1H NMR (Fig. 4.1C).
As reported in previous studies [160, 161], the peaks shown at 1.0-1.1 ppm corresponded to
protons from CH3 whereas the peaks at 1.1-1.3 ppm were attributed to protons from CH2 of
stearic acid in SA-CS spectrum. Compared to the native CS, the remaining peaks of CS
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saccharide units did not change significantly after the reaction, including single peak at 3.1
ppm (H–2), multiple peaks at 3.6-3.9 ppm (H–3 to H–6), and single peak at 2.0 ppm, which
represented the protons of N-acetyl group [162]. The results indicated that SA was
successfully conjugated to the CS backbone and the SA-CS still contained a significant
amount of NH2 functional groups.

4.3.2. Preparation and characterization of Oxdex

A well-known periodate oxidation method was adopted to produce Oxdex with multiple
functional aldehyde groups which serve as a macromolecular cross-linker [163], as shown in
Fig. 4.2A. In FT-IR spectrum, the absorption peak at 1732 cm-1 that corresponding to the
stretching of the carbonyl (C=O stretching) from an aldehyde group was detected in Oxdex
[164]. Such band was not observed in the pristine dextran, indicating the successful oxidation
of dextran. The structure of Oxdex was also confirmed by 1H NMR (Fig. 4.2B). The spectra of
both pristine dextran and Oxdex exhibited peaks (1-6) in the range of 3.2-4.0 ppm attributed
to the protons from the glucose unit. However, compared to the pristine dextran, several
distinctive peaks in the range of 5.0-6.0 ppm were observed in the spectrum of Oxdex,
corresponding to the protons from the hemiacetal structures [164, 165]. The result confirmed
that Oxdex was successfully prepared.

4.4. Conclusion

In this work, the SA-CS conjugate was successfully synthesized using free radical induced
grafting method, which was confirmed by FT-IR and NMR. The presence of aldehyde groups
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in the Oxdex was confirmed using nuclear magnetic resonance spectroscopy (NMR). In the
next chapter, the development of biopolymer-based nanoparticles using SA-CS, NaCas, GLA,
and Oxdex was investigated.
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4.5. Figures and tables
Figure 4.1 Proposed mechanism (A), FT-IR spectra (B) and 1H NMR spectra (C) of SA-CS
conjugate.
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Figure 4.2 Proposed mechanism of fabrication of Oxdex (A), FT-IR spectra (B) and 1H NMR
spectra (C) of pristine dextran and Oxdex.
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Chapter 5
Biocompatible polymeric nanoparticles with
innovative structural design for oral delivery of
lipophilic bioactives

Part of this chapter, including tables and figures, has been published in Food Hydrocolloids,
2018, 89, 386-395 and reprinted with permission from Elsevier
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5.1. Background

In recent years, biopolymer-based nanoparticles have been considered as an effective
intracellular delivery system for most biologics, such as proteins [166], nucleic acids [167],
nutrients and drugs [10], providing novel strategies for the therapeutic and preventive
treatment of chronic diseases. Tremendous efforts have been made to explore various routes
for delivery of biologics, including inhalation, ingestion, intravenous and intramuscular injection,
as well as some exotic methods, i.e., gene gun bombardment and microneedle-based
transdermal delivery [168]. At present, oral delivery is widely recognized as a preferred route
for biologics due to its convenience, minimal invasiveness, cost-effectiveness, and patient
compliance in both short- and long-term treatment [169]. However, numerous challenges for
oral delivery exist. Because of the wide range of pH variation and enzymatic degradation in
GI tract [170], it is difficult for many types of nanoparticles, especially natural polymers-based
nanoparticles, to maintain their structural integrity. Furthermore, the mucus layer on the
surface of GI tract and tight junctions of the epithelium act as other barriers that prevent
absorption of nanoparticles, resulting in a rapid clearance in small intestine.

In this study, we aimed to explore the lipophilic bioactives delivery potential of biopolymerbased nanoparticles prepared by NaCas with SA-CS coating. To further improve the
encapsulation efficiency, physical stability and sustained release in simulated GI conditions,
the nanoparticles were chemically cross-linked by different cross-linkers, i.e. GLA and Oxdex,
and the effects of crosslinking were investigated.
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5.2. Experimental design

5.2.1. Preparation and optimization of SA-CS/NaCas nanoparticles

The SA-CS/NaCas nanoparticles were prepared according to a modified method of Hu et
al [171] based on ionic gelation between SA-CS and NaCas. The stock solutions of SA-CS
and NaCas were separately prepared by dissolving in DI water at 2 mg/mL, respectively. To
prepare nanoparticles, 5 mL of NaCas solution with various concentrations was added
dropwise to 10 mL of SA-CS aqueous solution (2 mg/mL) to reach the SA-CS to NaCas mass
ratios of 2:1, 3:1, 4:1, 5:1, and 6:1. For each SA-CS/NaCas mass ratio, the mixture was stirred
gently for 30 min at room temperature, followed by heating at 80 °C for 30 min and then cooling
to room temperature. The as-prepared colloidal nanoparticles (1.8 mg/mL) were subject to
physicochemical characterizations as follows: particle size and polydispersity index (PDI) were
determined by dynamic light scattering (DLS) at 173°under room temperature using a Nano
Zetasizer ZS (Malvern Instruments, Ltd., Worcestershire, UK); zeta potential was measured
in DTS1070 cells by laser Doppler microelectrophoresis technology through the same
instrument. The stability of nanoparticles in simulated GI tract were conducted in simulated
gastric fluid (SGF, containing 2.0 g/L NaCl and 2.917 g/L HCl) and simulated intestinal fluid
(SIF, 0.616 g/L NaOH and 6.8 g/L H2KO4P) at both fasting and fed conditions. Briefly, 100 μL
of freshly prepared sample was added into 900 μL of SGF at pH 2 (fasting-state condition)
and pH 4 (fed-state condition) with 1 mg/mL of pepsin, as well as 900 μL of SIF at pH 7 with
10 mg/mL of pancreatin. Then, the mixture was incubated in a 37 °C water bath for 2, 2 and 4
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h, respectively. After each incubation, nanoparticles were tested for particle size, PDI and zeta
potential following the same methods as mentioned above.

5.2.2. Optimization of crosslinking process

The nanoparticles with optimal SA-CS to NaCas mass ratio was selected to further
optimize the crosslinking process. The stock solutions of two cross-linkers, i.e., both GA and
Oxdex, were prepared by dissolving in DI water at 20 mg/mL. To investigate the effects of
different crosslinking methods on the physicochemical properties of nanoparticles, four
crosslinking treatments were performed: nanoparticles S1 and S2 were crosslinked by 1.8 and
3.6 mg/mL Oxdex, respectively, for 2 h and then crosslinked by GA (0.3 mg/mL) for another 2
h; nanoparticles S3 and S4 were crosslinked by GA (0.3 mg/mL) for 2 h and then crosslinked
by 1.8 and 3.6 mg/mL Oxdex, respectively, for another 2 h. For comparison, four controls were
also prepared as follows: (C1) nanoparticles without crosslinking treatment, (C2) nanoparticles
were crosslinked by GA (0.3 mg/mL) for 2 h only; (C3) nanoparticles were crosslinked by
Oxdex (3.6 mg/mL) for 2 h only; (C4) nanoparticles were crosslinked by GA (0.3 mg/mL) for 2
h and then mixed with native dextran (3.6 mg/mL) for another 2 h. Detailed sample information
is tabulated in Table 5.1. All crosslinking processes were carried out at room temperature.
Freshly prepared samples and controls were checked for particles size, PDI, zeta potential
and stability in simulated GI fluids at both fasting and fed conditions.

To obtain the lowest concentration of GLA required to maintain the stability in simulated
GI fluids, nanoparticles were crosslinked by various concentrations of GLA (0.30, 0.18, 0.12,
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and 0.09 mg/mL) for 2 h, and then crosslinked by Oxdex (3.6 mg/mL) for another 2 h.
Afterwards, each sample was checked for particle size, PDI, zeta potential and the stability in
simulated GI fluids at both fast and fed conditions. The nanoparticles prepared by the optimal
process were used in the following experiments.

5.2.3. Transmission electron microscopy (TEM)

TEM was employed to observe the morphology of freshly prepared nanoparticles, and to
monitor the morphological changes of nanoparticles during stability test in simulated GI fluids.
Briefly, 3 μL of each diluted sample (0.5 mg/mL) was deposited on a plasma cleaned carboncoated TEM grid (CF400-CU, Electron Microscopy Science) for 2 min. Then, the grid was
rinsed off by 100 μL of 0.5% uranyl acetate stain solution and air dried completely. Finally, the
grid was examined using a TEM (FEI, Tecnai 12 G2, Spirit, BioTWIN, Netherlands) and
images were obtained by a CCD camera (AMT 2k XR40).

5.2.4. Storage stability of nanoparticles

The stability of nanoparticles was determined during storage at refrigeration condition
(4 °C) and room temperature (25 °C) for up to 28 days. At each time point (day 1, 4, 7, 10, 14,
21, and 28), samples were subject to particle size and PDI measurement by DLS.

5.2.5. Morphology of nanoparticles dried powder

The spray-dried powders were obtained using a Nano Spray Dryer B-90 (BÜCHI
Labortechnik AG, Flawil, Switzerland). Based on our previous study [172], the nanoparticles
were diluted to 1 mg/mL with DI water prior to spray drying. The drying conditions were as
65

follows: compressed air as the drying gas, flow rate of 100-110 L/min, mesh size of 4.0 μm,
inlet temperature at 100 °C. The freeze-dried nanoparticles were obtained using FreeZone
Console Freeze Dry System (Labconco, Kansas City, MO, USA). Then, both spray-dried and
freeze-dried solid samples were deposited onto double adhesive carbon conductive tape and
observed under SEM (JSM-6330F, JEOL Ltd., Tokyo, Japan).

5.2.6. Cytotoxicity and cellular uptake studies

Caco-2 cells (ATCC, Manassas, VA, USA), a human intestinal cell line, were cultured in
low-glucose DMEM equilibrated with 5% CO2 and 95% air in a 37 °C humidified chamber. The
medium was supplemented with 10% fetal bovine serum, 100 U/mL of penicillin, 100 μg/mL
of streptomycin, 1× vitamins, and 1× non-essential amino acids. The cultures were split after
the cells reached 80-90% confluence. Caco-2 cells in passage between 10 and 20 were used
in this study.

The freshly prepared SA-CS/NaCas nanoparticles were dialyzed against DI water for 12 h
with changes of water every 2 h to remove unreacted GLA and Oxdex. The dialyzed
nanoparticles were diluted 10, 50, and 100 times (equivalent to concentration of 0.46, 0.092
and 0.046 mg/mL based on total mass of nanoparticles, respectively) with low-glucose DMEM
supplemented with 100 U/mL of penicillin, 100 μg/mL of streptomycin, 1× vitamins, and 1×
non-essential amino acids. To determine cytotoxicity, Caco-2 cells were seeded at the density
of 1.5×104 cells per well in a 96-well plate. After cell reached ~90% confluency, they were
treated with different concentrations of samples in five replicates. After 24 h of incubation,
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cytotoxicity was measured using a Cell Counting Kit-8 (Dojindo Inc., Rockville, MD, USA)
according to the manufacturer’s instruction. The absorbance at 450 nm was measured using
the BioTek’ Synergy Mx (BioTek, Winooski, VT, USA).

To visualize nanoparticles using a fluorescence microscope, fluorescein isothiocyanate
(FITC) labeled nanoparticles were prepared according to a previously reported procedure with
slight modifications.[173] Briefly, NaCas was dissolved in carbonate buffer (25 mM, pH 9.5)
with a concentration of 2 mg/mL. To this solution, FITC was added to reach the NaCas to FITC
mass ratio of 10:1 and the mixture was gently stirred for 1.5 h at room temperature in the dark.
Free FITC was removed by dialyzing against Tris buffer (50 mM, pH 8.5) at 4 °C until no
fluorescence was detected in the dialysate using a fluorescence spectrometer LS55 (Perkin
Elmer, Waltham, MA, USA). Afterwards, the FITC labeled NaCas was adjusted to pH 7.0 with
0.6 M HCl and then used to prepare FITC-nanoparticles. Caco-2 cells (1×105 cells/well) were
seeded in a 12-well plate and incubated until a monolayer with 90% confluency was formed.
FITC-nanoparticles (2 mg/mL) were added and incubated for 12 h at 37 °C. Subsequently, the
cell nuclei were stained by Hoechst® 33342 dye (Invitrogen, Carlsbad, CA, USA) for 15 min
at 37 °C, followed by washing twice by DPBS to remove any free nanoparticles. The
fluorescent images were recorded by an Observer A1 fluorescence microscope (ZEISS,
Oberkochen, Germany).

5.2.7. Nutrient delivery applications
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Curcumin was used as a model bioactive to investigate the encapsulation capacity of SACS/NaCas nanoparticles. Prior to preparation of nanoparticles, curcumin was first solubilized
in

NaCas

using

a

pH-driven

technique

without

organic

solvent

[174].

Four

curcumin/nanoparticles mass ratios, i.e. 0.5%, 1%, 1.5%, and 2%, were tested. Briefly, various
amount of curcumin powder was dissolved in NaCas solution (1.32 mg/mL) at pH 12 to induce
the deprotonation and solubilization of curcumin under alkaline condition. After stirring at 600
rpm for 45 min, the mixture was adjusted to pH 7, followed by centrifugation (8,000 g, 20 min)
to remove undissolved curcumin. The supernatant containing solubilized curcumin in NaCas
was collected for preparation of nanoparticles. The curcumin-encapsulated nanoparticles
were ultrafiltered using Amicon® Ultra centrifugal filters (Merck KGaA, Darmstadt, Germany)
with a MWCO of 10,000 Da. After centrifugation at 8,000 g for 20 min, the concentration of
permeated free curcumin in the receiving reservoir was measured by a UV-Vis
spectrophotometer (Evolution 201, Thermo Scientific, Waltham, MA, USA) at 430 nm. The
encapsulation efficiency (EE) and loading capacity (LC) were calculated according to the
following formulas, respectively.
EE (%) =

𝑇𝑜𝑡𝑎𝑙 𝐶𝑢𝑟 − 𝑢𝑙𝑡𝑟𝑎𝑓𝑖𝑙𝑡𝑟𝑎𝑡𝑒𝑑 𝐶𝑢𝑟
× 100%
𝑇𝑜𝑡𝑎𝑙 𝐶𝑢𝑟

LC (%) =

𝑇𝑜𝑡𝑎𝑙 𝐶𝑢𝑟 − 𝑢𝑙𝑡𝑟𝑎𝑓𝑖𝑙𝑡𝑟𝑎𝑡𝑒𝑑 𝐶𝑢𝑟
× 100%
𝑇𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑛𝑎𝑛𝑜𝑐𝑜𝑚𝑝𝑙𝑒𝑥𝑒𝑠

where “Cur” refers to curcumin, and “Total mass of nanoparticles” refers to the total mass of
SA-CS, NaCas, GLA, Oxdex, and curcumin used in the preparation of nanoparticles.
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The pH dependent release kinetics of curcumin from SA-CS/NaCas nanoparticles was
determined according to a dialysis method [58]. A release medium was prepared by premixing
equal volume of ethanol with simulated gastric or intestinal fluid to create a sink condition for
curcumin [175, 176]. Briefly, 3 mL of curcumin-loaded nanoparticles were sealed in a dialysis
tube with MWCO of 12,000-14,000 Da and immersed into 60 mL of simulated gastric release
medium at either fast-state condition (pH 2) or fed state condition (pH 4). After incubation at
37 °C with gentle shaking for 2 h, the dialysis tube was transferred into 60 mL of simulated
intestinal release medium for another 4 h incubation at 37 °C. At pre-determined time intervals,
1 mL of release medium was withdrawn to measure the curcumin concentration using a UVVis spectrophotometer (Evolution 201, Thermo Scientific, Waltham, MA, USA) at 430 nm and
1 mL of fresh release medium was replenished to maintain the constant volume. For
comparison, free curcumin and NaCas solution containing curcumin prepared by pH-driven
technique were diluted with DI water to the same curcumin concentration as in nanoparticles
and used as controls.

5.3. Results and discussion

5.3.1. Preparation and optimization of SA-CS/NaCas nanoparticles

The proposed mechanism of the SA-CS/NaCas nanoparticles preparation was described
in Fig. 5.1. In the present study, the main driving force to form polymeric nanoparticles is the
electrostatic attraction between positively charged SA-CS and negatively charged NaCas, as
well as hydrophobic interactions between SA segments on CS and hydrophobic residues of
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NaCas. Two polymers were first mixed together to induce the complexation via electrostatic
interactions for the formation of nanoparticles. The above mixture was then adjusted to pH 4.6
(isoelectric point of NaCas) and heated at 80 °C for 30 min to induce the partial selfaggregation of NaCas molecules and thus enhance the hydrophobic and electrostatic
interactions between the two polymers.

As the mass ratio of SA-CS to NaCas plays an important role in the formation of
nanoparticles, its effects on physicochemical properties were studied. A series of SA-CS to
NaCas mass ratios, including 2:1, 3:1, 4:1, 5:1 and 6:1 were comprehensively tested and the
particle size, PDI, and zeta potential of resultant nanoparticles are shown in Fig. 5.2. Based
on the criteria of small particle size, low PDI, relatively large count rate, the SA-CS to NaCas
mass ratio of 3:1 was selected. For comparison, a control prepared by replacing the SA-CS
with native CS at 3:1 mass ratio to NaCas exhibited significantly larger particle size (821.3 nm)
and higher PDI value (0.34) than SA-CS/NaCas nanoparticles (data not shown). It could be
attributed to the greater molecular weight and strong electrostatic interactions while weak
hydrophobic interactions between native CS and NaCas, resulting in the formation of large
and heterogeneous complexes [142]. Therefore, the SA-CS was superior to native CS in
preparing nanoparticles.

Afterwards, the in vitro stability in simulated GI fluids was measured. The pristine SACS/NaCas nanoparticles (C1) was incubated in both SGF and SIF, and then subjected to the
measurement of particle size and PDI. As shown in Table 5.2, when C1 was incubated in SGF
at pH 4, the particulate properties were maintained although a significant reduction in particle
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size (from 156.4 nm to 125.6 nm) and a slight increase in PDI (from 0.10 to 0.20) were noticed.
Nevertheless, in both SGF at pH 2 and SIF at pH 7, precipitations were observed. In SGF at
pH 2, the SA-CS failed to protect NaCas from destabilization by low pH and pepsin, which
resulted in the rupture of nanoparticulate structure. In SIF, where the neutral pH is close to the
pKa value of amino groups on SA-CS, the protonation level was minimal and so severe
aggregation occurred. Thus, it is necessary to exploit other mechanisms to further stabilize
SA-CS/NaCas nanoparticles against aggregation and enzymatic degradation in the GI
condition. It has been previously reported that glutaraldehyde (GLA) acts as a cross-linker that
reacts rapidly with amino groups of proteins or polysaccharides [177, 178]. Alternatively, the
periodate oxidized dextran (Oxdex) with two aldehyde groups has been demonstrated to
possess the similar reaction mechanism as GLA and been applied as a macromolecular crosslinker to stabilize delivery systems [150-152]. Hence, as tabulated in Table 5.1, SA-CS/NaCas
nanoparticles (S1-S4) and controls (C1-C4) were prepared using different crosslinking
methods to determine the effects of two cross-linkers on nanoparticulate properties and
colloidal stability.

5.3.2. Optimization of crosslinking process

Compared with pristine SA-CS/NaCas nanoparticles C1 (un-crosslinked), no significant
differences in particle size, PDI and zeta potential were observed for both crosslinked C2 and
C3 (as shown in Fig. 5.3A and B), suggesting that nanoparticulate properties were not
affected by crosslinking through either GLA or Oxdex. However, it is noteworthy that two crosslinkers had distinct effects on the stability of nanoparticles in simulated GI fluids (Table 5.2).
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When crosslinked by GLA alone, C2 exhibited improved stability in SGF at pH 2 compared to
C1, even though slightly larger particle size (164.9 nm) and higher PDI value (0.24) than
freshly prepared nanoparticles (152.9 nm and 0.09, respectively) were observed.
Nevertheless, C2 failed to maintain the nanoparticulate structure in SIF at pH 7. On the
contrary, C3 crosslinked by Oxdex alone was stable in SIF at pH 7, while precipitated in SGF
at pH 2. Previous studies showed that GLA has a high crosslinking efficiency for proteins by
forming intra and intermolecular bonding between amino groups [179]. As a small molecular
cross-linker, GLA could also migrate into the core of nanoparticles to bridge the amino groups
of NaCas and SA-CS, leading to improved stability under acidic condition by preventing protein
molecules from severe aggregation. Oxdex, on the other hand, is a macromolecular crosslinker that could only react with the SA-CS backbone on the surface of nanoparticles but could
not migrate into the core to bridge NaCas molecules. This explains the better stability under
intestinal condition at neutral pH, but precipitation occurred at gastric condition due to
precipitation of NaCas in the core. Therefore, we hypothesized that if the nanoparticles were
crosslinked by both GLA and Oxdex, it would be possible to obtain nanoscale delivery vehicles
that were stable under both gastric and intestinal conditions.

To study the effects of different crosslinking sequences and different concentrations of
cross-linker on the stability of nanoparticles, four samples (S1 to S4 in Table 5.1) were
prepared. There was no significant difference in particle size, PDI value and zeta potential
among four crosslinked samples (Fig. 5.3A and B). To further study the optimal crosslinking
process, the GI stability of four samples was carried out and results were presented in Table
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5.2. Notably, S1 and S2, which shared same crosslinking sequence (Oxdex first and then GLA)
but different concentration of Oxdex, exhibited discrepant stability in SIF at pH 7. The particle
size and PDI value of S2 after incubation in SIF were 161.2 nm and 0.13, respectively, while
S1 formed large precipitates. The same trend was observed in S3 and S4, suggesting that the
concentration of Oxdex played a critical role in maintaining the nanoparticulate structure in
SIF. On the other hand, S2 and S4 shared the same concentrations of two cross-linkers but
varied in crosslinking sequence. Compared to S2, S4 exhibited better stability in SGF at pH 2
with significantly smaller size and lower PDI value. This comparison revealed that the
sequence of crosslinking matters and the most desirable GI stability of nanoparticles was
achieved only if the small molecular cross-linker GLA was applied before the macromolecular
crosslinked Oxdex. Based on the above observation, one could deduce that if the
nanoparticles were first crosslinked by Oxdex from the surface, the migration of GLA into the
inner core was hindered resulting in a lower crosslinking efficiency with NaCas, which led to
poorer stability in SGF at pH 2.

Finally, C4 was prepared as a control to demonstrate that the crosslinking mechanism of
Oxdex was the chemical reaction between aldehyde and amino groups, instead of depletion
stabilization, which is the repulsion between Oxdex and nanoparticles. It has been reported
that the aggregation of nanoparticles can be prevented by the presence of free polymer due
to the high-energy depletion zone between closely interacting particle surfaces [180].
Nevertheless, the free polymer will be diluted after the nanoparticles were incubated in SIF
and its stabilization effects will be lost. As a result, the nanoparticles will aggregate again. As
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expected, precipitation was observed in SIF at pH 7 if Oxdex was replaced by native dextran
at the equivalent concentration. This result confirmed the successful preparation of Oxdex and
its promising crosslinking effects. Collectively, S4 was selected as the optimal sample for the
following studies.

A big concern of using GLA as the cross-linker is its potential toxicity. The acute toxicity of
GA in rat models has been investigated in many studies [181, 182], and its LD50 was reported
as 100 mg/kg. Although the concentration of GA used in the present study is way below its
toxicity level, it was desirable to determine the minimal concentration needed to maintain the
stability of nanoparticles under acidic condition. In this section, nanoparticles crosslinked by
different concentrations of GLA were prepared to minimize its toxicity. Fig. 5.3C and D showed
that nanoparticulate properties were not affected by the concentration of GLA. It is interesting
to note that although the stability of nanoparticles in SGF at pH 4 and SIF at pH 7 seemed to
be independent of studied GLA concentrations, their stability in SGF at pH 2 was compromised
when GLA concentration was decreased to 0.12 mg/mL, where significantly greater PDI was
observed (Table 5.3). In addition, the particle size increased to 183.2 nm and the PDI value
was over 0.3 when the GLA concentration was further reduced to 0.09 mg/mL. Therefore, 0.18
mg/mL was considered as the minimum concentration for GLA that could stabilize the
nanoparticles in simulated GI fluids. Thus far, the optimal preparation method of SACS/NaCas nanoparticles was obtained as follows: 5 mL of NaCas was added dropwise into
10 mL of 2 mg/mL SA-CS aqueous solution with 3:1 as the mass ratio of SA-CS to NaCas.
The mixture was stirred for 30 min at 600 rpm under room temperature, followed by heating
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for 30 min at 80 °C. Afterwards, the nanoparticles were crosslinked by GLA (0.18 mg/mL) for
2 h and Oxdex (3.6 mg/mL) for another 2 h, consecutively. The particle size, PDI value, and
zeta potential of optimal SA-CS/NaCas nanoparticles were 148.6 nm, 0.10, and +21.4 mV,
respectively.

5.3.3. Transmission electron microscopy (TEM)

The freshly prepared colloidal nanoparticles were negatively stained with uranyl acetate
and observed under TEM. As shown in Fig. 5.4A, the dimension of freshly prepared
nanoparticles was in the range of 80-100 nm with a spherical shape and smooth surface,
suggesting the monodispersity and well-controlled particle size. The discrepancy between
particle size measured by TEM and DLS is well supported by literatures [183, 184]. The
images obtained by TEM is in the dry and compact state. However, the DLS analysis is a
measurement of colloidal dimension of nanoparticles which are associated with solvent
molecules. So, the results are often influenced by non-covalent interactions among
nanoparticles, such as hydrogen bond and van der Waals forces. In order to further
demonstrate the stability of nanoparticles in simulated GI fluids, the morphology measurement
using TEM was carried out after the nanoparticles were incubated in SGF (pH 2 and 4), and
SIF (pH 7) individually. In both the fasting- and fed-state SGF condition, although
nanoparticles exhibited homogeneous dimension and spherical shape (Fig. 5.4B and C),
rough and eroded surface was observed under fasting-state SGF at pH 2 (Fig. 5.4B). This
may be attributed to the dissociation and rupture of Oxdex layer caused by the harsh acidic
environment. In SIF at pH 7, the nanoparticles became more heterogeneous and the size was
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slightly increased (Fig. 5.4D), possibly due to the reduced protonation of SA-CS as a response
to the neutral pH resulting in the swelling and expansion [185]. It is noteworthy that the
tendency of nanoparticulate stability in simulated GI fluids observed under TEM was in
consistent with that from DLS results.

5.3.4. Storage stability of nanoparticles

The storage stability of the nanocomplexes was tested under refrigeration (4 °C) and room
temperature (25 °C) by monitoring the particle size and PDI value at designated time points.
A gradual decrease of particle size of nanocomplexes was observed for both storage
conditions, with a faster rate under room temperature (Fig. 5.5A). This is conceivable that
NaCas, as a milk protein molecule, may be slowly degraded due to bacterial growth during
the storage at ambient condition. Even though slight fluctuations of PDI values were observed
at both storage conditions, they remained in the range of 0.09-0.14 at all times (Fig. 5.5B),
suggesting the monodistribution of particle size throughout the storage test. In addition, the
morphology of nanocomplexes under two different storage conditions was also determined
using TEM at day 28 (Fig. 5.5C and D). Both of them had the same features as freshly
prepared samples, indicating that the nanocomplexes were able to maintain their
nanoparticulate properties and structure for at least 4 weeks under the studied conditions.

5.3.5. Morphology of nanoparticles dried powder

Two drying techniques were applied to obtain solid powder samples from colloidal
nanocomplexes, and the morphology of powders was observed under SEM, including
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structure, shape, size and surface feature. Fig. 5.6A presented the SEM image of nano spray
dried sample. Although most of the particles had a spherical shape, the wide distribution of
particle size and the difference in the surface feature was observed. Some particles with the
size smaller than 500 nm had a smooth surface, while other particles with dramatically larger
size (around 1 μm) had dented surface. This observation generally agreed with our previous
studies that spray drying process usually produced dry powder particles with the
heterogeneous dimension [99, 171]. Nevertheless, our results indicated that dry particles
obtained by nano spray drying technology were significantly smaller than those generated by
traditional spray drying technology [186, 187]. Conversely, as observed in Fig. 5.6B, freeze
dried nanocomplexes appeared to have film-like morphology with a few spherical
nanoparticles being scattered on the surface, indicating a much lower yield of nanocomplexes
using freeze-drying process.

5.3.6. Cytotoxicity and cellular uptake studies

The cytotoxicity was expressed as the normalized viability compared with control cells. As
shown in Fig. 5.7A, all different concentrations of nanoparticles showed no toxicity to Caco-2
cells. Labeling with FITC did not significantly alter particulate characteristics of the
nanoparticles, including particle size, PDI and zeta potential (data not shown). The
internalization of FITC-labeled nanoparticles in Caco-2 cells were evident as shown in Fig.
5.7B. The bright field image confirmed that all cells remained viable with stretched morphology,
indicating the non-cytotoxicity of nanoparticles. The green fluorescence was clearly observed
in the cytoplasm region surrounding nuclei reflected by blue fluorescence of Hoechst® 33342
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staining dye. This observation was indicative of that the nanoparticles were taken up by the
cells and mainly distributed in the cytoplasm. Interestingly, few green fluorescence signals
were overlapped with blue fluorescence, which indicated the potential existence of FITC
molecules in the nucleus. The internalized nanoparticles may be degraded in the lysosomes
and the degraded products, such as FITC-labeled peptides and/or amino acids, could be
further transported to nucleus for cell metabolism. This hypothesis was well corroborated with
several studies. For instance, the co-localization of chitosan-based and other polymeric
nanoparticles with lysosomes has been reported in Hela cells following the endocytosis and
the migration of nanoparticles towards the perinuclear region with extended incubation time
has also been observed, suggesting the degradation of macromolecular carriers at the later
lysosomal stage and then translocation of degraded products into nucleus [188, 189]. However,
more studies about cellular uptake and intracellular trafficking are needed to further
demonstrate the detailed mechanisms.

5.3.7. Nutrient delivery applications

Curcumin has been widely used as a phytochemical of hydrophobic nature to investigate
the loading capacity of various colloidal nanoparticles [190, 191]. An innovative pH-driven
method [174] was applied in the present study. Curcumin was first solubilized in alkaline
condition at pH 12. Under this condition, NaCas sub-micelles were dissociated, and
encapsulation of curcumin into NaCas self-aggregated nanoparticles was attained via strong
hydrophobic interactions during the subsequent neutralization process. Two formulations with
different curcumin loading were prepared and their characteristics are depicted in Table 4.
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Compared to the blank nanoparticles, their particle size was significantly increased to 175-180
nm, which could be explained by the expansion of nanoparticles due to curcumin loading into
the core [192]. Notably, the strong hydrophobic interactions between curcumin and NaCas
favored the formation of nanoparticles with significantly narrower size distribution, i.e., PDI
values were reduced to 0.11-0.12 [193]. The encapsulation efficiency and actual loading
capacity of nanoparticles with 1.0% original loading were 97.5% and 0.96%, respectively. This
is indicative of that increasing curcumin loading from 0.5% to 1.0% did not compromise the
encapsulation capability of nanoparticles. Therefore, nanoparticles with 1.0% curcumin
loading was selected for further experiment.

The controlled release of curcumin from nanoparticles was carried out in SGF at pH 2 and
4, respectively mimicking fasting- and fed-state gastric conditions, followed by transferring to
SIF (pH 7). As depicted in Fig. 5.8, free curcumin diffused rapidly at pH 2 and 4, reaching
78.9% and 65.7%, respectively in the first 2 h, and a final 90-100% cumulative release was
observed under SIF condition. Compared to free curcumin, curcumin in NaCas exhibited a
slower diffusion in both fasting- and fed-state conditions. In SGF at pH 2, the cumulative
release of curcumin from NaCas reached 37.8% and 61.8% at the end of SGF and SIF
condition and a burst effect was observed at the beginning of both conditions. In contrast, the
diffusion of curcumin from NaCas was slower in SGF at pH 4 and a mild burst effect was
noticed at the beginning of SIF condition. This difference at fasting- and fed-state gastric
conditions could be explained by the protonation of NaCas at lower pH and the reduction of
hydrophobic interactions, leading to the dissociation of curcumin from NaCas. After
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nanoparticles were formed by complexing NaCas core with SA-CS and further crosslinked by
GLA and Oxedx, the kinetic release rate in both SGF conditions was appreciably reduced and
the burst effect at the beginning of SIF condition became negligible. With that said, less than
15% cumulative release of curcumin was observed at the end of incubation. This observation
strongly indicated that the crosslinked polymeric network of NaCas, SA-CS and Oxdex holds
promising features for oral delivery of hydrophobic bioactives.

5.4. Conclusion

In this work, an innovative nanoscale delivery system was constructed by complexing
NaCas, SA-CS and Oxdex under mild reaction conditions. The nanoparticles consisted of an
amphiphilic NaCas/SA-CS core and a spontaneously but covalently crosslinked Oxdex
coating layer. The optimal preparation method was obtained by evaluating the effects of SACS and NaCas mass ratio, crosslinking sequence and the concentration of cross-linkers on
the nanoparticulate properties and the stability in simulated GI fluids. The DLS data and TEM
images collectively suggested the compact polymeric structure which was able to maintain its
integrity throughout the GI tract, as well as during long-term storage. The Caco-2 cell studies
revealed the non-cytotoxicity and cellular uptake of the nanoparticles. Encapsulation of
curcumin into nanoparticles was achieved by an organic solvent-free and pH-driven process.
The promising controlled release profile of nanoparticles in both fasting- and fed-state GI
conditions, along with the positive surface charge under neutral conditions, demonstrated its
potential as oral delivery vehicles for hydrophobic bioactives.
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5.5. Figures and tables
Figure 5.1 Proposed mechanism of fabrication of SA-CS/NaCas nanoparticles. SGF,
simulated gastric fluid; SIF, simulated intestinal fluid.
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Figure 5.2 Effect of mass ratio of SA-CS to NaCas on nanoparticles’ properties (A) particle
size and PDI (polydisperisty index); (B) Count rate; (C) Zeta potential. The values sharing
different superscript letters were statistically different at p < 0.05.
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Figure 5.3 Effect of crosslinking processes on: (A) particle size and PDI (polydisperisty index);
(B) Zeta potential, and effect of GLA concentration on: (C) particle size and PDI (polydisperisty
index); (D) Zeta potential: The values sharing different superscript letters were statistically
different at p < 0.05.
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Figure 5.4 TEM images of nanoparticles as (A) freshly prepared; (B) incubated in SGF (pH
2.0); (C) incubated in SGF (pH 4.0); (D) incubated in SIF (pH 7.0). HV = 80.0 kV.
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Figure 5.5 Stability of optimal nanoparticles in 4 °C and 25 °C during 28 days (A) particle size;
(B) PDI (polydisperisty index); TEM images (C) stored for 28 days at 4 °C; (D) stored for 28
days at 25 °C.
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Figure 5.6 SEM images of (A) spray dried nanoparticles and (B) freeze dried nanoparticles.
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Figure 5.7 Viability of treated Caco-2 cells with SA-CS/NaCas nanoparticles (A). Control:
Caco-2 cells treated with 2.5 mL of media (100 U/mL of penicillin, 100 μg/mL of streptomycin,
1x vitamins, and 1x non-essential amino acids) without FBS. (B) Cellular uptake of FITCnanoparticles in Caco-2 cells. Green fluorescence is from FITC labeled NaCas in
nanoparticles; blue fluorescence is from Hoechst® 33342 nuclei staining.
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Figure 5.8 The kinetic release profile of free curcumin and curcumin from nanoparticles under
different simulated gastric and intestinal conditions. (A) fasting-state condition; (B) fed-state
condition.
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Table 5.1 Formulations of SA-CS/NaCas nanoparticles.
Crosslinking method
Samples

Aqueous phase (15 mL)

Sequence 1

Sequence 2

SA-CS

NaCas

Oxdex

GA

GA

Oxdex

(mg)

(mg)

(mg/mL)

(mg/mL)

(mg/mL)

(mg/mL)

S1

20

6.7

1.8

0.3

—

—

S2

20

6.7

3.6

0.3

—

—

S3

20

6.7

—

—

0.3

1.8

S4

20

6.7

—

—

0.3

3.6

C1

20

6.7

—

—

—

—

C2

20

6.7

—

—

0.3

—

C3

20

6.7

3.6

—

—

—

C4

20

6.7

Crosslinked by GA (0.3 mg/mL) for 2 h and then mixed
with native dextran (3.6 mg/mL) for another 2 h
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Table 5.2 Stability of nanoparticles with different crosslinking procedures in SGF and SIF.
Samples

pH=2.0

pH=4.0

pH=7.0

Size (nm)

PDI

Size (nm)

PDI

Size (nm)

PDI

S1

150.8 ± 8.3b

0.27 ±0.02ab

121.6 ± 0.4a

0.20 ± 0.01abc

Precipitates

Precipitates

S2

167.6 ± 6.5a

0.29 ± 0.03a

125.4 ± 3.8a

0.21 ± 0.01a

161.2 ± 4.9a

0.13 ± 0.01b

S3

151.7 ± 1.4b

0.19 ± 0.02cd

127.8 ± 2.1a

0.16 ± 0.02cd

Precipitates

Precipitates

S4

159.0 ± 3.2b

0.23 ± 0.02bcd

126.9 ± 2.1a

0.24 ± 0.04abc

152.5 ± 16.0ab

0.20 ± 0.05a

C1

Precipitates

Precipitates

125.6 ± 2.5a

0.20 ± 0.01abc

Precipitates

Precipitates

C2

164.9 ± 2.4a

0.24 ± 0.02abc

124.8 ± 1.3a

0.16 ± 0.01d

Precipitates

Precipitates

C3

Precipitates

Precipitates

122.9 ± 3.8a

0.21± 0.02ab

131.6 ± 1.8b

0.24 ± 0.01a

C4

151.0 ± 0.7b

0.17 ± 0.02d

128.2 ± 0.5a

0.17 ± 0.01bcd

Precipitates

Precipitates

*Data were expressed as mean ± standard deviation. The values sharing different superscript
letters in the same column were statistically different at p < 0.05. PDI, polydispersity index.

90

Table 5.3 Stability of nanoparticles with different GLA concentrations in SGF and SIF.
GLA (mg/mL)

pH=2.0

pH=4.0

pH=7.0

Size (nm)

PDI

Size (nm)

PDI

Size (nm)

PDI

0.30

159.0 ± 3.2b

0.23 ± 0.02b

126.9 ± 2.1ab

0.19 ± 0.02a

152.5 ± 16.0a

0.20 ± 0.02a

0.18

152.9 ± 1.3b

0.23 ± 0.01b

130.4 ± 2.5a

0.24 ± 0.04a

157.0 ± 18.0a

0.20 ± 0.05a

0.12

165.6 ± 4.2b

0.29 ± 0.02a

123.7 ± 0.9bc

0.19 ± 0.02a

164.2 ± 21.0a

0.27 ± 0.10a

0.09

183.2 ± 10.0a

0.33 ± 0.02a

122.3 ± 0.7c

0.19 ± 0.03a

164.2 ± 20.0a

0.23 ± 0.05a

*Data were expressed as mean ± standard deviation. The values sharing different superscript
letters in the same column were statistically different at p < 0.05. PDI, polydispersity index.

91

Table 5.4 Characteristics of curcumin-loaded SA-CS/NaCas nanoparticles
Loading (%)

Size (nm)

PDI

Zeta potential (mV)

EE (%)

ALC (%)

0.5

175.0 ± 5.8

0.11 ± 0.02

+21.8 ± 0.6

98.4 ± 0.1

0.48 ± 0.0

1.0

179.8 ± 2.5

0.12 ± 0.03

+22.8 ± 0.4

97.5 ± 0.0

0.96 ± 0.0

*Data were expressed as mean ± standard deviation. PDI, polydispersity index; EE,
encapsulation efficiency; ALC, actual loading capacity. The 0.5 and 1.0% loading of curcumin
respectively equals to 0.023 and 0.042 mg/mL curcumin concentration in nanoparticles.
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Chapter 6
Preparation and characterization of biopolymerbased nanoparticles for oral delivery of astaxanthin
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6.1. Background

The main driving force to form the nanoparticles is the electrostatic attraction between
cationic SA-CS and anionic sodium caseinate, as well as hydrophobic interactions induced by
heating. Chemically crosslinking has been widely used to strengthen the interaction between
polyelectrolytes and maintain the integrity of nanoparticles in GI condition. However, the safety
concern of using toxic cross-linker is still remained.

Maillard reaction is a chemical reaction between amino acid and reducing sugars, usually
requiring the addition of heat [194]. The reactive carbonyl group of the sugar reacts with
the nucleophilic amino group of the amino acid, and forms a complex mixture of poorly
characterized molecules [195]. Studies have shown that the aldehyde groups on Oxdex react
with amino groups from amino acid and form nanoparticles with exceptional GI stability [196,
197]. Therefore, Oxdex will be used as non-toxic cross-linker to improve the stability of
nanoparticles in GI condition. In the preparation process, several factors will influence the
physicochemical properties of nanoparticles, such as Oxdex concentration, Maillard reaction
temperature and reaction time. One of the optimization methods, Box-Behnken response
surface methodology (RSM) design will be used to obtain the optimal nanoparticles. In addition,
the optimal nanoparticles will be characterized and ASTX will be used as a model hydrophobic
nutrient to investigate the encapsulation and delivery applications.

6.2. Experimental design

6.2.1. Preparation and optimization of SA-CS/NaCas/Oxdex nanoparticles
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The SA-CS/NaCas/Oxdex nanoparticles were prepared according to a modified method
of Hu et al. [171] based on ionic gelation between SA-CS and NaCas. The stock solutions of
SA-CS and NaCas were separately prepared by dissolving in DI water at 1.00 and 0.33 mg/mL,
respectively. To prepare nanoparticles, 5 mL of NaCas solution was added dropwise to 10 mL
of SA-CS aqueous solution to reach the SA-CS to NaCas mass ratios of 3:1. The mixture was
stirred gently for 30 min at room temperature, followed by adding Oxdex with various
concentrations and heating in water bath. To optimize the formulation, Box-Behnken quadratic
design was conducted with 15 randomized experiments and 3 center point replicates using
Design-Expert Software Version 8. The model is described by the following quadradic
equation:

Y = b0 + b1X1 + b2X2 + b3X3 + b12X1X2 + b13X1X3 + b23X2X3 + b11X12 + b22X22 + b33X32

Where Y is the measured response associated with factor level combinations; b0 is the
intercept and b1 to b33 are the regression coefficients computed from observed value of Y; X1,
X2, and X3 are the coded levels of independent variables. XiXj (i= 1, 2 or 3 and j= 1, 2 or 3)
and Xi2 (i= 1, 2 or 3) are the interaction and quadratic terms, respectively.

The independent factors (X) selected were mass ratio of SA-CS to Oxdex (X1), heating
temperature (X2), and heating time (X3), with three levels being low (-1), medium (0), and high
(+1) for each independent factor (Table 6.1). The dependent responses (Y) were particle size
(Y1), polydispersity index PDI (Y2), Δ particle size in SGF (Y3) and Δ particle size in SIF (Y4).
The experiment design matrix is shown in Table 6.2. The optimal formulation was based on
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the criteria of particle size at 100 to 130 nm, the minimum PDI, minimum Δ particle size in
SGF, and minimum Δ particle size in SIF. At the end, a new batch of nanoparticles with the
predicted levels of formulation factors was prepared to confirm the validity of the optimization
procedure.

6.2.2. Fourier transform infrared (FT-IR)

The FT-IR spectra of SA-CS, NaCas, Oxdex, and spray dried nanoparticles were recorded
on a Fisher Scientific Nicolet Is5 Spectrometer equipped with an iD7 ATR accessory (Thermo
Fischer Scientific Inc., Waltham, MA, USA) by scanning from 4000-500 cm-1 at a resolution of
4 cm-1 and analyzed using OMNIC software version 8.0.

6.2.3. Determination of encapsulation efficiency of ASTX

ASTX was used as a model bioactive to investigate the encapsulation capacity of
nanoparticles. Prior to preparation of nanoparticles, ASTX stock solution was prepared by
dissolving in dimethyl sulfoxide (DMSO) at 4 mg/mL. Then, ASTX with different concentrations
was pre-mixed with NaCas with stirring at room temperature for 30 min. Then the ASTXloaded nanoparticles were prepared in the same process as described in section 6.2.1.
Afterwards, the ASTX-loaded nanoparticles were centrifuged at 5,000 g for 10 min, and free
ASTX precipitate was collected and redissolved in acetone. The concentration of free ASTX
was measured using high performance liquid chromatography (HPLC).

The HPLC consisted of a modular system SPD-20AV (SHIMADZU, Japan) with diode
array detector. A 150 × 4.6 mm i.d. 3 μm C8 analytical column (YMC, Japan) was used at
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25 °C. A mobile phase of 100% methanol was used for astaxanthin analysis. The flow rate
was 1 mL/min, and the injection volume was 20 μL. The peak area of astaxanthin was
measured at a wavelength of 474 nm. The quantification used an external standard method,
linear regression equation for astaxanthin at 474 nm is: A = 3E+08C - 43154, R2=0.9993,
where C is the ASTX concentration (mg/mL), A is the peak area of ASTX.

The EE and LC were calculated according to the equations, respectively.

EE (%) =

LC (%) =

𝑇𝑜𝑡𝑎𝑙 𝐴𝑆𝑇𝑋 − 𝐹𝑟𝑒𝑒 𝐴𝑆𝑇𝑋
× 100%
𝑇𝑜𝑡𝑎𝑙 𝐴𝑆𝑇𝑋

𝑇𝑜𝑡𝑎𝑙 𝐴𝑆𝑇𝑋 − 𝐹𝑟𝑒𝑒 𝐴𝑆𝑇𝑋
× 100%
𝑇𝑜𝑡𝑎𝑙 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑛𝑎𝑛𝑜𝑝𝑎𝑟𝑡𝑖𝑐𝑙𝑒𝑠

where “Total mass of nanoparticles” refers to the total mass of SA-CS, NaCas, Oxdex, and
ASTX used in the preparation of nanoparticles.

6.2.4. Morphology of nanoparticles

TEM was employed to observe the morphology of empty nanoparticles, ASTX-loaded
nanoparticles and to monitor the morphological changes of nanoparticles during stability test
in simulated GI fluids. It was conducted according to the procedure in section 5.2.3. The spraydried powders of both empty nanoparticles and ASTX-loaded nanoparticles were obtained
and their morphology were observed under SEM following the procedure in section 5.2.5.

6.2.5. ABTS radical scavenging assay
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The ABTS radical scavenging activity of ASTX-loaded nanoparticles was carried out in 96well microplate according to the method that described in section 3.2.5. The ASTX-loaded
nanoparticles were tested at equivalent ASTX concentrations in a wide range, i.e., 0.5, 1, 2.5,
5, 10, 20, and 40 μg/mL. Free ASTX was dissolved in DMSO and then diluted with PBS to the
same range of concentration. The control was prepared by replacing sample with PBS, and
meanwhile the sample background (sample added in PBS without ABTS) was also measured
to avoid any interference of background color.

ABTS free radical scavenging activity (%) = (1 −

𝐴𝑠 − 𝐴𝑏
) × 100
𝐴𝑐

Where As, Ab, and Ac are the absorbance of the sample, background, and control, respectively.

6.2.6. Cytotoxicity of ASTX-loaded nanoparticles

LX-2, a human HSC cell line, were cultured in low-glucose DMEM equilibrated with 5%
CO2 and 95% air in a 37 °C humidified chamber. The medium was supplemented with 2%
fetal bovine serum, 100 U/mL of penicillin, 100 μg/mL of streptomycin, and 1× non-essential
amino acids. The cultures were split after the cells reached 80-90% confluence.

The ASTX-loaded nanoparticles were diluted at equivalent ASTX concentration of 10 μM
with low-glucose DMEM supplemented with 100 U/mL of penicillin, 100 μg/mL of streptomycin,
and 1× non-essential amino acids. To determine cytotoxicity, LX-2 cells were seeded at the
density of 3.0×103 cells per well in a 96-well plate. After cell reached ~90% confluency, they
were treated ASTX-loaded nanoparticles in five replicates. After 48 h of incubation, cytotoxicity
was measured using a Cell Counting Kit-8 (Dojindo Inc., Rockville, MD, USA) according to the
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manufacturer’s instruction. The absorbance at 450 nm was measured using the BioTek’
Synergy Mx (BioTek, Winooski, VT, USA). The cell was also treated with 0.2% DMSO, empty
nanoparticles, and 10 μM of ASTX in 0.2% DMSO as controls, respectively.

6.3. Results and discussion

6.3.1. Preparation and optimization of SA-CS/NaCas/Oxdex nanoparticles

A total of 15 experimental runs were performed for three levels and three factors according
to the response surface methodology using the Box-Behnken design. The variables used in
the study were selected based on the preliminary experiments. The quadratic equations
generated for different responses, including particle size (Y1), polydispersity index PDI (Y2), Δ
particle size in SGF (Y3) and Δ particle size in SIF (Y4) were shown as under:

Y1 = 109.28 + 13.2X1 + 8.27X2 + 7.71X3 + 10.3X1X2 + 6.50X1X3 – 0.92X2X3 + 1.81X12 – 1.13X22
– 2.77X32

Y2 = 0.13 – 0.00625X1 – 0.021X2 – 0.023X3 – 0.0025X1X2 + 0.020X2X3 + 0.00542X12 +
0.00042X22 + 0.00792X32

Y3 = 37.77 – 6.85X1 – 9.56X2 – 12.56X3 + 0.55X1X2 + 0.85X1X3 + 10.38X2X3 – 10.22X12 –
13.40X22 – 2.44X32

Y4 = 170.70 – 475.00X1 + 26.15X2 – 48.68X3 – 80.08X1X2 + 59.67X1X3 + 15.67X2X3 + 323.12X12
+ 32.81X22 – 53.28X32
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The summary of analysis results for observed response is shown in Table 6.3, The positive
coefficient of a factor in the above quadratic equation indicates the enhancement or a
synergistic effect of that particular response, vice versa. The lack-of-fit was not significant in
all the responses at 95% confidence level. The values of various statistical parameters,
including mean square values (MS), F-value, p-value, multiple correlation coefficients (R2),
standard deviation (SD), coefficient of variation (C.V%), and predicted residual sum of squares
are shown in Table 6.4. The results indicated that the quadratic model was best-fitted for all
the responses studied.

The particle size measured for different batches showed wide variation from 91.7 to 148.8
nm with the selected levels of variations. Significant effects of independent variables were
revealed by one-way ANOVA analysis. The most significant factors affecting the particle size
are mass ratio of SA-CS to Oxdex (X1), heating temperature (X2), heating time (X3), the
interaction between mass ratio of SA-CS to Oxdex and heating time (X1X2), as shown in Table
6.3. The particle size significantly increased with increase of the amount of Oxdex and heating
temperature, as well as the elongation of Maillard reaction time. In our previous study, it has
been proved that the main driving force to form polymeric nanoparticles is the electrostatic
attraction between negatively charged NaCas core and positively charged SA-CS coating, as
well as hydrophobic interactions between SA segments and hydrophobic residues of NaCas.
The aldehyde groups of Oxdex could react with amino groups of both NaCas and SA-CS via
Maillard reaction, resulting in the formation a SA-CS/Oxdex conjugate cover on the surface of
protein molecules [151]. Therefore, the larger particle size may be attributed to thicker SA100

CS/Oxdex coating, caused by the higher concentration of Oxdex and temperature. Meanwhile,
the reaction time on different heating temperature also had a significant influence on the
particle size, which was corroborated with previous literature [198].

In the current study, the PDI of nanoparticles ranged from 0.11 to 0.2 for various factor
level combinations. The most significant factors affecting the PDI are heating temperature (X2),
heating time (X3), and the interaction between heating temperature and heating time (X 2X3).
As shown in Fig. 6.1B1, at the certain concentration of Oxdex, PDI of nanoparticles was
decreased from 0.16 to 0.11 with the increase of heating temperature, which could be
attributed to the formation of more homogenous SA-CS/Oxdex coating. The similar trend was
also observed in Fig. 6.1B2, indicating that both temperature and Maillard reaction time have
significant negative effect on PDI. Our results were supported by the literature that Oxdex
could not be absorbed onto the surface of NaCas core at the initial stage of heating due to the
kinetic and thermodynamic process of Schiff-base formation [198]. However, more Oxdex was
reacted with NaCas and SA-CS and less free Oxdex was remained in the aqueous phase,
resulting in the formation of more uniform coating layer and more ordered structure of
nanoparticles, and more narrow size distribution. Nevertheless, the highest PDI was observed
when nanoparticles were heated at 80 oC for 45 min. It could be ascribed to the aggregation
caused by intermolecular conjugation among nanoparticles.

The in vitro stability in simulated GI fluids is an important parameter of nanoparticles as an
oral delivery system. In this experiment, the stability was evaluated by measuring the particle
size change after incubation of nanoparticles in SGF or SIF, compared with original size, which
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expressed as Δ particle size in SGF and Δ particle size in SIF. The most significant factors
affecting the Δ particle size in SGF are X2 and X3, indicating that stability of nanoparticles in
SGF was significantly affected by heating temperature and heating time. The lower Δ particle
size in SGF was observed under higher heating temperature and longer heating time, which
could be explained by the formation of well-ordered and uniform coating layer, resulting in the
better protection for nanoparticles against acidic gastric fluid and pepsin. This result was
consistent with that from the influence of heating temperature and time on PDI of nanoparticles.
However, the particle size was significantly increased under high heating temperature,
especially when the temperature raised to 85 oC. It revealed that the optimal combination of
heating temperature and heating time is required to achieve a good stability of nanoparticles
in SGF while maintaining the small particle size.

As described in section 5.3.1, the protonation level of SA-CS was minimal in SIF where
the neutral pH is close to the pKa value of amino groups on SA-CS. As a result, the SA-CS
coating was disassociated and severe aggregation was formed. Therefore, the Oxdex plays
an important role in stabilization of nanoparticles and maintaining the stability in SIF. In this
experiment, most factors did not dramatically affect the Δ particle size in SIF, evidenced by
the small values of coefficient with insignificance. The only factor that significantly affect Δ
particle size in SIF was mass ratio of SA-CS to Oxdex (X1). As shown in Fig. 6.1D1 & D2, the
Δ particle size in SIF was significantly decreased with the increase of amount of Oxdex at
different heating temperature and heating time. At low level of X1, the severe aggregation was
observed after the incubation of nanoparticles in SIF. It demonstrated that insufficient Oxdex
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failed to form the SA-CS/Oxdex coating layer and protect nanoparticles in SIF, resulting in the
disassociation of SA-CS from NaCas. Nevertheless, at high level of X1, in which the
concentration of Oxdex reached to 1.25 mg/mL, the lower Δ particle size in SIF was obtained.
It is noteworthy that the lowest Δ particle size in SIF was -8.2%, which refers to the decreased
particle size after the incubation of nanoparticles in SIF. It might be ascribed to the degradation
of SA-CS/Oxdex coating layer by pancreatin.

The three-dimensional (3D) response surface plots generated by the Design-Expert
software was used to acquire the optimized formulation of the SA-CS/NaCas/Oxdex
nanoparticles. The response-fitting results indicated that optimized SLNs with small particle
size, low PDI value, and low Δ particle size in SGF and SIF, were obtained at the mass ratio
of SA-CS to Oxdex of 1:1.95, heating temperature of 76 oC, and heating time of 43 min,
respectively. Therefore, three new batches of SA-CS/NaCas/Oxdex nanoparticles with the
predicted levels of formulation factors was prepared to validate the optimization procedure.
The optimized formulation had particle size of 119.7 nm, PDI of 0.11, Δ particle size in SGF of
4.85%, and Δ particle size in SIF of 3.29%. Table 6.5 showed that the average experimental
values of the three batches of nanoparticles prepared using the optimized range were very
close the predicted values.

6.3.2. Fourier transform infrared (FT-IR)

The FT-IR spectra of SA-CS, NaCas, Oxdex, and optimized nanoparticles were presented
in Fig. 6.2. SA-CS exhibited its amphiphilicity by several characteristic peaks as described in
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section 4.3.1, including primary amine (N–H bending) at 1617 cm-1, amide I (C=O stretching)
at 1617 cm-1, carbonyl from ester bonds (C=O stretching) at 1692 cm-1, and alkane from SA
(C–H stretching) at 2877 cm-1. The strong amide I and amide II absorptions, and O–H
stretching at 1637, 1514, and 3281 cm-1 was observed from NaCas, as well as C–H stretching
at the region of 2920–2960 cm-1, indicating its strong amphiphilicity [199]. In the spectrum of
Oxdex, the stretching of the carbonyl (C=O stretching) from aldehyde groups at 1732 cm-1 was
observed as described in section 4.3.2.

The optimized nanoparticles shared a high similarity in their characteristic peaks, i.e.
amide I and amide II absorptions at 1647 and 1530 cm-1 from both SA-CS and NaCas. The
shift of peaks in the region of amide bands could be explained by electrostatic interactions
between two polymers [200]. The O–H and C–H stretching were also observed from
nanoparticles. Noteworthy, the nanoparticles only showed one band at 1727 cm-1, which may
be attributed to the overlapping of carbonyl stretching from ester bond in SA-CS and unreacted
aldehyde groups in Oxdex.

6.3.3. Determination of encapsulation efficiency of ASTX

The poor water-solubility of ASTX has been proved in previous literatures, while it is
soluble in several organic solvents, such as DMSO, acetone and chloroform [201]. In the
current study, the DMSO was adopted to prepare ASTX stock solution so that the
encapsulation procedure could be facilitated. Prior to preparation of nanoparticles, ASTX stock
solution was first mixed with NaCas due to its high affinity to lipophilic bioactive compounds.
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Three batches of nanoparticles with different ASTX loading efficiency, i.e. 1%, 3%, and 5%
were tested. As depicted in Fig. 6.3A, compared to the empty nanoparticles control, the
particle size of ASTX-loaded nanoparticles was in a range of 145-198 nm which significantly
increased with the increase of loaded ASTX. It may be explained by the expansion of
nanoparticles due to ASTX loading into the NaCas core. The same trend was observed from
PDI results, indicating that the nanoparticles became more heterogeneous when more ASTX
were encapsulated. Encapsulation of ASTX did not alter the surface charge of nanoparticles,
as no significant change of zeta potential were detected for all different batches, as shown in
Fig. 6.3B. Nevertheless, the amount of loaded ASTX exhibited negative affect on the
encapsulation efficiency of nanoparticles. With the increase of loaded ASTX from 1% to 5%,
the encapsulation efficiency decreased from 81.5% to 65.3%. This is indicative of that
increasing ASTX loading gradually compromised the encapsulation capability of nanoparticles.
In addition, the risk of cytotoxicity may increase with the 5% ASTX loaded nanoparticles as
more DMSO was introduced into the aqueous phase. Collectively, the ASTX-loaded
nanoparticles with 3% loading efficiency was selected as the optimal formulation. The
encapsulation efficiency of as-prepared nanoparticles was 70.2%, which equaled 72.1 μM of
ASTX was encapsulated into the SA-CS/NaCas/Oxdex nanoparticles.

6.3.4. Morphology of nanoparticles

The optimized nanoparticles were negatively stained with uranyl acetate and observed
under TEM. As shown in Fig. 6.4A, the dimension of freshly prepared nanoparticles was in
the range of 80-100 nm with a spherical shape and smooth surface, suggesting the
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monodispersity and well-controlled particle size. In order to further validate the stability of
nanoparticles in simulated GI fluids, the morphology measurement using TEM was carried out
after the nanoparticles were incubated in SGF (pH 2), and SIF (pH 7) individually. Unlike the
rough and eroded surface of nanoparticles under SGF which was observed in section 5.4, the
particle size, smooth surface and monodispersity of as-prepared nanoparticles were
maintained after the incubation in SGF (Fig. 6.4B), suggesting the superior protection effect
of SA-CS/Oxdex coating layer formed by Maillard reaction than that of GLA in harsh acidic
environment. As demonstrated in section 5.4, the increased particle size and heterogeneous
distribution of nanoparticles crosslinked by GLA and Oxdex were observed in SIF. However,
no significant swelling and expansion of particle size were seen in current study, indicating
that the SA-CS/Oxdex coating layer formed by Maillard reaction was able to prevent reduction
of protonation level of SA-CS in neutral pH. Noticeably, the slightly rough surface of
nanoparticles was observed in Fig. 6.4C, possibly due to the degradation of coating layer
caused by digestive enzymes, which was consistent with that from DLS results. The
morphology of optimized ASTX-loaded nanoparticles was also tested. Compared to the empty
nanoparticles, the ASTX-loaded nanoparticles exhibited larger particle size and more
heterogeneous size distribution (Fig. 6.4D), which was consistent with DLS results.
Interestingly, a brighter field in the center area was observed in ASTX-loaded nanoparticles,
which might be ascribed to the encapsulation of lipophilic ASTX.

The SEM images of nano spray dried nanoparticles were presented in Fig. 6.5. Both empty
nanoparticles and ASTX-loaded nanoparticles showed spherical shape but wide size
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distribution. Some particles exhibited a size of 500 nm with smooth surface, while other
particles had dramatically larger size (around 1 μm) with dented surface.

6.2.5. ABTS radical scavenging assay

The antioxidant activity of ASTX has been associated with the beneficial effects on chronic
diseases such as macular degradation, cardiovascular diseases, and cancer [202, 203].
Compared to other carotenoids, such as zeaxanthin, lutein and β-carotene, ASTX has been
reported to be 10 times stronger antioxidant activity [204]. However, the poor water solubility
of ASTX limited its benefits in the aqueous environment. Due to improved water dispersibility,
the encapsulation of lipophilic compounds in nanoparticles has been considered as a
promising strategy to facilitate their antioxidant activity. As shown in Fig. 6.7, the scavenging
capacity against ABTS radicals of free ASTX, empty nanoparticles and ASTX-loaded
nanoparticles were tested. At a wide range of concentrations studied (0.5–40 μg/mL), free
ASTX showed almost no scavenging activity, attributed to poor dispersibility in PBS and limited
contact with ABTS radicals. The scavenging activity of empty nanoparticles slightly increased
with the increase of concentration. Nevertheless, the dispersion of ASTX was improved after
being encapsulated into nanopartilces, resulting in the significantly higher antioxidant activity
than that of free ASTX. The 85.6% of ABTS radicals scavenging capacity was observed at 40
μg/mL.

6.3.6. Cytotoxicity of ASTX-loaded nanoparticles
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The cytotoxicity was expressed as the normalized viability compared with control cells. As
shown in Fig. 6.8, both empty nanoparticles and ASTX-loaded nanoparticles showed no
toxicity to LX-2 cells.

6.4. Conclusion

In this study, Oxdex was applied to strengthen the stability of SA-CS/NaCas hybrid
nanoparticles via Maillard reaction. The formulations were compressively optimized through
response surface methodology, including mass ratio of SA-CS to Oxdex, heating temperature,
and heating time. The successfully prepared nanoparticles were confirmed by FT-IR. The DLS
data and TEM images collectively suggested the compact polymeric structure of optimized
nanoparticles which was able to maintain the integrity throughout the GI tract due to strong
covalent bond between aldehyde groups of Oxdex and amino groups of NaCas/SA-CS. The
SA-CS/Oxdex coating layer was critical in formation of nanoparticles with smooth surface and
monodispersity. Encapsulation of ASTX into nanoparticles with a 70% EE was achieved by
assistance of DMSO. The promising controlled release profile of nanoparticles in GI fluid,
along with the positive surface charge under neutral conditions, demonstrated its potential as
oral delivery vehicles for lipophilic bioactives.
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6.5. Figures and tables
Figure 6.1 Surface response plots showing the effect of mass ratio of SA-CS to Oxdex, heating
temperature and heating time on particle size (A1-A3), PDI (B1-B3), Δ particle size in SGF
(C1-C3), and Δ particle size in SIF (D1-D3), respectively.
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Figure 6.2 FT-IR spectra of SA-CS, NaCas, Oxdex, and optimized nanoparticles.
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Figure 6.3 Characteristics of ASTX-loaded SA-CS/NaCas/Oxdex nanoparticles: (A) particle
size and encapsulation efficiency; (B) PDI; (C) Zeta potential. The values sharing different
superscript letters were statistically different at p < 0.05.
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Figure 6.4 TEM images of nanoparticles as (A) freshly prepared; (B) incubated in SGF (pH
2.0); (C) incubated in SIF (pH 7.0). HV = 80.0 kV.
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Figure 6.5 SEM images of (A) spray dried empty nanoparticles and (B) spray dried ASTXloaded nanoparticles.
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Figure 6.6 Proposed mechanism of fabrication of ASTX loaded SA-CS/NaCas/Oxdex
nanoparticles.
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Fig. 6.7 Scavenging activity against ABTS radical of ASTX-loaded nanoparticles, free ASTX,
and empty nanoparticles. Data are presented as means ± SD of triplicates.
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Figure 6.8 Viability of treated LX-2 cells with ASTX-loaded nanoparticles. Control: Caco-2 cells
treated with 0.2% DMSO, empty nanoparticles, and 10 μM of ASTX in 0.2% DMSO.
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Table 6.1 Experimental factors and levels.
Factors

Level (-1)

Level (0)

Level (+1)

Mass ratio of SA-CS to Oxdex, X1

1:1

1:1.5

1:2

Heating temperature (oC), X2

75

80

85

Heating time (min), X3

15

30

45
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Table 6.2 Experiment design (Box-Behnken design)
Formulation

X1

X2

X3

1

-1

-1

0

2

1

-1

0

3

-1

1

0

4

1

1

0

5

-1

0

-1

6

1

0

-1

7

-1

0

1

8

1

0

1

9

0

-1

-1

10

0

1

-1

11

0

-1

1

12

0

1

1

13

0

0

0

14

0

0

0

15

0

0

0

118

Table 6.3 Statistical analysis results of particle size (Y1), PDI (Y2), Δ particle size in SGF
(Y3), and Δ particle size in SIF (Y4).
Particle size (Y1)

Δ particle size in SGF (Y3)

PDI (Y2)

Δ particle size in SIF (Y4)

Parameters
Coefficient

P-value

Coefficient

P-value

Coefficient

P-value

Coefficient

P-value

Constant*

109.28

0.000

0.13

0.000

37.77

0.000

170.70

0.000

X1

13.20

0.003

-0.00625

0.119

-6.85

0.064

-475.00

0.000

X2

8.27

0.020

-0.021

0.001

-9.56

0.021

26.15

0.421

X3

7.71

0.026

-0.023

0.001

-12.56

0.007

-48.68

0.164

X1*X2

10.30

0.031

-0.0025

0.618

0.55

0.899

-80.08

0.116

X1*X3

6.50

0.121

0.000

1.000

0.85

0.843

59.67

0.217

X2*X3

-0.92

0.801

0.020

0.008

10.38

0.052

15.67

0.726

X1*X1

1.81

0.638

0.00542

0.319

-10.22

0.061

323.12

0.000

X2*X2

-1.13

0.768

0.00042

0.935

-13.40

0.025

32.81

0.489

X3*X3

-2.77

0.479

0.00792

0.167

-2.44

0.590

-53.28

0.279
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Table 6.4 Summary of the results of regression analysis for response, and analysis of variation
for particle size (Y1), PDI (Y2), Δ particle size in SGF (Y3), and Δ particle size in SIF (Y4).
DF

SS

MS

F

p value

R2

SD

C.V%

Model

9

3062.00

340.22

7.03

0.0224

0.9268

6.95

6.43

Residual

5

241.84

48.37

Total

14

3303.84

Model

9

0.0099

0.00110

12.48

0.0063

0.9574

0.0093

7.01

Residual

5

0.0004

0.00009

Total

14

0.0103

6.30

0.0283

0.9189

8.17

34.23

35.55

0.0005

0.9846

84.40

25.41

Parameters
Particles size (nm)

PDI

Δ particle size in SGF (%)
Model

9

3783.43

420.38

Residual

5

333.76

66.75

Total

14

4117.19

Δ particle size in SIF (%)
Model

9

2.279E+006

2.532E+005

Residual

5

35612.66

7122.53

Total

14

2.315E+006
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Table 6.5 Comparison of the actual and predicted values in the nanoparticles prepared under
predicted optimum conditions.
Response variable

Predicted values

Actual values

Particles size (nm)

116.0

119.7 ± 0.9

PDI

0.13

0.11 ± 0.05

Δ particle size in SGF (%)

2.60

4.85 ± 0.03

Δ particle size in SIF (%)

3.85

3.29 ± 0.02
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Chapter 7
Conclusions and future directions
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In the first step of this project, a GA modified CS conjugate was fabricated via eco-friendly
free radical induced grafting approach as a coating material for the further preparation of
nanoparticle delivery system. Even though the GA-CS was successfully prepared and
significant higher in vitro antioxidant activity against different types of free radicals were
observed than that of native CS, GA-CS may not be suitable for encapsulation and delivery
for lipophilic bioactive compounds due to poor stability and low amphiphilicity. More efforts
should be done to explore the CS derivative as more suitable coating material.

Therefore, the SA was introduced onto CS backbone via the same method to prepare
alternative CS conjugate for the preparation of nanoparticles in the second study. The SA-CS
was successfully fabricated and confirmed by FT-IR and NMR. It is highly expected that the
great amphiphilicity of SA-CS could facilitate the interaction with lipophilic compounds. To
further strengthen the integrity of nanoparticles and improve its stability in GI tract, Oxdex was
prepared as a macromolecular cross-linker by periodate oxidation method.

In the third study, an innovative nanoscale delivery system was prepared using NaCas,
SA-CS and Oxdex under mild reaction conditions. The nanoparticles were formed with
amphiphilic NaCas core coated with SA-CS layer. The mass ratio of SA-CS to NaCas was
evaluated to obtain the minimum particle size and homogenous size distribution. Different
cross-linkers, including GLA and Oxdex were applied to stabilize the nanoparticles in
simulated GI fluids. The concentration of GLA was further optimized to lower the risk of
cytotoxicity. The cellular uptake of the nanoparticles was confirmed by Caco-2 cells studies.
The obtained nanoparticles exhibited excellent encapsulation capacity for curcumin,
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evidenced by sustained release profile in GI-conditions. However, the utilization of two crosslinkers makes the fabrication method complicated and the crosslinking process was timeconsuming. In addition, the introduction of GLA in nanoparticles may cause toxicity problems
for applications in nutraceutical, food pharmaceutical. So, a simple and toxic cross-linker free
fabrication method should be developed.

Thus, in the last study, only Oxdex was utilized to strengthen the interaction between
different ingredients in nanoparticles via Maillard reaction. The effects of three major factors
on the physicochemical properties and GI stability of nanoparticles, including mass ratio of
SA-CS to Oxdex, heating temperature and heating time were systematically evaluated by
response surface methodology. Unlike the spontaneous formed covalent bond between
Oxdex and SA-CS in the third study, the interaction between Oxdex and both NaCas and SaCS which triggered by Maillard reaction greatly improved the stability of nanoparticles in
simulated GI fluids. Encapsulation of ASTX into nanoparticles was achieved with a 70% EE.
The promising controlled release profile of nanoparticles in GI conditions demonstrated its
potential as oral delivery vehicles for hydrophobic bioactives.

Overcoming multiple barriers in GI tract remains the major challenge for oral delivery of
bioactive compounds. Even though the current studies have demonstrated the excellent
protective effect of biopolymer-based nanoparticles for lipophilic bioactives against wide pH
variation and enzymatic degradation in GI tract, more efforts should focus on understanding
the mucus permeation of as-prepared nanoparticles. Besides, comprehensive studies
concerning the mechanism of intracellular trafficking and basolateral release of nanoparticles
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are needed. These mechanisms are strong evidence to prove the enough GI stability before
moving to the animal experiments. Furthermore, the current research focusing on
development of nanoparticles oral delivery system for lipophilic bioactives has been primarily
concentrated more at in vitro studies. The simulated GI conditions are limited to mimic the
complex and dynamic GI tract of mice or human. Therefore, there is an urgent need for
evaluation of biological fate of as-prepared nanoparticles using in vivo models.

Besides, biopolymer-based nanoparticles have been considered as an effective
intracellular delivery system for the therapeutic and preventive treatment of chronic diseases,
such as liver fibrosis. It is known that the activation of HSC in a quiescent state into matrixproducing myofibroblasts is a central event in response to an insult of chronic liver injury.[205,
206] The highly proliferative activated HSC are able to migrate and produce large quantity of
proteins, such as interstitial collagen (mainly type I and III), α-smooth muscle actin (α-SMA),
proteoglycans and matrix metalloproteinase,[207, 208] resulting in the development of liver
fibrosis. Over the last decades, the interest of utilizing biopolymer-based nanoparticle delivery
systems for the treatment of liver fibrosis has been drastically increased. Because of the
functional groups on the surface, the as-prepared nanoparticles have the potential to be further
engineered by grafting specific ligands for overproduced receptors on HSC cell membrane
and achieve targeting delivery. In addition, different nutrients/drugs other than lipophilic
bioactive compounds, such as siRNA could be incorporated into as-prepared nanoparticles to
test the therapeutic effects for liver fibrosis, thus, explore the application of nanoparticles in
pharmaceutical.
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